KR20190001284A - Filter material for removing heavy metals and formaldehyde - Google Patents

Filter material for removing heavy metals and formaldehyde Download PDF

Info

Publication number
KR20190001284A
KR20190001284A KR1020170081030A KR20170081030A KR20190001284A KR 20190001284 A KR20190001284 A KR 20190001284A KR 1020170081030 A KR1020170081030 A KR 1020170081030A KR 20170081030 A KR20170081030 A KR 20170081030A KR 20190001284 A KR20190001284 A KR 20190001284A
Authority
KR
South Korea
Prior art keywords
filter
formula
derivative
chemical formula
formaldehyde
Prior art date
Application number
KR1020170081030A
Other languages
Korean (ko)
Inventor
구영삼
손기남
Original Assignee
(주) 에프엔지리서치
손기남
구영삼
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주) 에프엔지리서치, 손기남, 구영삼 filed Critical (주) 에프엔지리서치
Priority to KR1020170081030A priority Critical patent/KR20190001284A/en
Publication of KR20190001284A publication Critical patent/KR20190001284A/en

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D39/00Filtering material for liquid or gaseous fluids
    • B01D39/14Other self-supporting filtering material ; Other filtering material
    • B01D39/16Other self-supporting filtering material ; Other filtering material of organic material, e.g. synthetic fibres
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24DCIGARS; CIGARETTES; TOBACCO SMOKE FILTERS; MOUTHPIECES FOR CIGARS OR CIGARETTES; MANUFACTURE OF TOBACCO SMOKE FILTERS OR MOUTHPIECES
    • A24D3/00Tobacco smoke filters, e.g. filter-tips, filtering inserts; Filters specially adapted for simulated smoking devices; Mouthpieces for cigars or cigarettes
    • A24D3/06Use of materials for tobacco smoke filters
    • A24D3/14Use of materials for tobacco smoke filters of organic materials as additive
    • AHUMAN NECESSITIES
    • A62LIFE-SAVING; FIRE-FIGHTING
    • A62BDEVICES, APPARATUS OR METHODS FOR LIFE-SAVING
    • A62B18/00Breathing masks or helmets, e.g. affording protection against chemical agents or for use at high altitudes or incorporating a pump or compressor for reducing the inhalation effort
    • A62B18/02Masks

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Business, Economics & Management (AREA)
  • Emergency Management (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention provides a filter having a function of removing heavy metal and formaldehyde, which includes, as an active component, one or more selected among trientine or a trientine derivative indicated as chemical formula 1, cyclene or a cyclene derivative indicated as chemical formula 2, and cyclam or a cyclam derivative indicated as chemical formula 3. In the chemical formulae: R_1, R_2, R_3, R_4, R_5, and R_6 are independently hydrogen, -R_7-COOH, or salt thereof; and R_7 is an aliphatic of C_1 to C_5, a substituted or non-substituted aromatic ring, or a heterocyclic six-membered or five-membered ring.

Description

중금속 및 포름알데히드 제거능을 가지는 필터{Filter material for removing heavy metals and formaldehyde}BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a filter for removing heavy metals and formaldehyde,

본 발명은 중금속과 포름알데히드를 효과적으로 제거하기 위한 필터에 관한 것으로, 보다 상세히는 가정용·자동차용 공기청정기, 에어컨 등의 다양한 공조시스템에 이용될 수 있는 공기 필터, 담배 필터, 공기마스크에 관한 것이다.The present invention relates to a filter for effectively removing heavy metals and formaldehyde, and more particularly, to an air filter, a cigarette filter, and an air mask that can be used in various air conditioning systems such as home air cleaners for automobiles and air conditioners.

오늘날 대기오염에 따른 미세먼지 발생이 나날이 증가하고 있어 환경 문제로 대두되고 있다. 미세먼지 차단을 위해 외출시 공기 마스크의 착용은 이제 보편화되는 추세에 있고, 실내 공기 정화를 위해 크고 작은 다양한 공기청정기가 판매되고 있고, 아파트와 같은 주택 건설시 각종 필터가 장착된 환기시스템이 도입되고 있는 실정이다.Today, the generation of fine dust due to air pollution is increasing day by day, and it is becoming an environmental problem. The use of air masks when going out for the purpose of blocking fine dust is now becoming commonplace, and various air cleaners large and small are sold for indoor air purification, ventilation systems equipped with various filters are introduced for the construction of houses such as apartments In fact.

미세먼지(PM10)는 평균 입경 10㎛ 이하, 초미세먼지(PM2.5)는 평균 입경 2.5㎛ 이하의 먼지로서 천식, 폐 기능 저하 등 각종 호흡기 질환과 피부염, 알레르기, 아토피 등 각종 피부 질환을 일으키는 요인으로 알려져 있다.The fine dust (PM 10 ) has an average particle diameter of 10 μm or less and the ultrafine dust (PM 2.5 ) has an average particle diameter of 2.5 μm or less. It is a kind of dust that causes various skin diseases such as asthma, lung function, and various respiratory diseases such as dermatitis, It is known as a factor.

미세먼지에는 지역, 환경, 계절 등에 따라 차이가 있으나 Hg(수은), Pb(납), Cd(카드뮴), As(비소), Cr(크롬), Cu(구리), Ni(니켈), Zn(아연), Mn(망간), Co(코발트), Sn(주석) 등 유해 중금속이 약 20% 정도로 다량 함유되어 각종 질환을 유발하는 것으로 보고되어 있다.Fine dusts may vary depending on the area, environment, and season, but may include Hg, Pb, Cd, As, Cr, Cu, Ni, Zinc), Mn (manganese), Co (cobalt), and Sn (tin) are contained in a large amount of about 20%, causing various diseases.

이러한 미세먼지, 중금속을 제거하기 위하여 시스템에 맞게 다양한 소재, 규격의 필터들이 개발되고, 판매되고 있다. 이러한 필터는 집진방식에 따라 여과식, 정전식, 충돌점착식, 흡착식 필터, 집진입경에 따라 조진용, 중진용, 미진용, 가스제거용 필터 등으로 구분되는 데, 단일 필터 뿐만 아니라 여러 종류의 필터를 겹쳐 제작된 복합 필터들이 이용되고 있다.In order to remove such fine dust and heavy metals, filters of various materials and specifications are developed and sold for the system. These filters are divided into filtration type, electrostatic type, collision adhesion type, adsorption type filter, dust type filter, dust type filter, dust type filter and gas removing filter according to dust collection type. Have been used.

필터의 소재로는 종이 필터, 부직포 필터, 염화비닐 필터, 헤파(HEPA)필터와 카본, 활성탄, 제오라이트, 실리카겔, 알루미나, 산화제2철 등 각종 흡착제가 첨가된 소재 등이 있으나, 이들 소재들은 미세먼지 특히 중금속과 1급 발암물질인 포름알데히드의 흡착성능이 아직 만족할 만한 수준에 있지는 않다. 헤파(HEPA)필터는 등급에 따라 0.3㎛ 이하의 미세먼지까지 제거할 수 있으나, 그 비용 비싸고 중금속, 포름알데히드의 흡착성능 역시 아직 한계가 있다.The materials of the filter include paper filters, nonwoven filters, vinyl chloride filters, HEPA filters, and materials to which various adsorbents such as carbon, activated carbon, zeolite, silica gel, alumina and ferric oxide are added, In particular, the adsorption performance of heavy metals and formaldehyde, a primary carcinogen, is not yet satisfactory. The HEPA filter can remove fine dust of 0.3 μm or less depending on the grade, but it is expensive, and the adsorption performance of heavy metals and formaldehyde is still limited.

한편, As(비소), 카듀믐(Cd), Ni(니켈) 등과 같은 유해 중금속들은 미세먼지 외에도 연초(담배) 성분에 포함되어 있어 흡연시 니코틴, 티르, 유해 가스와 함께 호흡기로 유입되어 폐암과 같은 질병을 유발하는 것으로 알려져 있다. 일반적인 담배는 흡연시 중 타르 및 니코틴, 일산화탄소 등을 거르기 위해 아세테이트 토우(Acetate Tow) 섬유 소재 담배필터가 있고, 필터 성능을 증가시키기 위하여 다공성 흡착제인 활성탄 또는 제오라이트 등이 첨가된 것이 있다. 그러나 이와 같은 활성탄과 제오라이트는 니코틴이나 타르 제거에는 어느 정도 효과가 있으나, 중금속, 포름알데히드 등의 흡착 제거에는 큰 효과가 없다.On the other hand, harmful heavy metals such as As (arsenic), cadmium (Cd) and Ni (nickel) are included in tobacco as well as fine dust, and they are introduced into the respiratory tract together with nicotine, It is known to cause the same disease. Common cigarettes include an Acetate Tow fiber tobacco filter to filter tar, nicotine, and carbon monoxide during smoking, and activated carbon or zeolite, which is a porous adsorbent, to enhance filter performance. However, such activated carbon and zeolite have some effect on the removal of nicotine and tar, but they do not have a great effect on adsorption removal of heavy metals, formaldehyde and the like.

본 발명은 상기와 같은 문제를 해결하기 위한 것으로, 중금속과 포름알데히드를 효과적으로 제거할 수 있는 공기 필터 소재를 제공하고, 이러한 필터를 이용하여 공기청정기, 에어컨, 공기순환시스템 등 각종 공조장치에 이용될 수 있는 공기 필터, 담배 필터, 공기 마스크를 제공하는 데 그 목적이 있다.The present invention has been made to solve the above-mentioned problems, and it is an object of the present invention to provide an air filter material capable of effectively removing heavy metals and formaldehyde, and to provide an air filter material that can be used in various air conditioners such as air cleaners, air conditioners, The purpose is to provide air filter, cigarette filter, air mask.

상기 목적을 달성하기 위하여 본 발명은, 중금속과 포름알데히드 제거를 위한 유효성분으로 하기 화학식 1로 표시되는 트리엔틴 또는 트리엔틴 유도체, 하기 화학식 2로 표시되는 사이클렌 또는 사이클렌 유도체, 하기 화학식 3으로 표시되는 사이클람 또는 사이클람 유도체 중에서 선택된 1종 이상을 포함하는, 중금속 및 포름알데히드 제거능을 가지는 필터를 제공한다.In order to accomplish the above object, the present invention provides a process for producing a compound of formula (I), which comprises, as an active ingredient for removing heavy metals and formaldehyde, a trientine or trientine derivative represented by the following formula And a cyclic or cyclic derivative represented by the general formula (3).

[화학식 1][Chemical Formula 1]

Figure pat00001
Figure pat00001

[화학식 2](2)

Figure pat00002
Figure pat00002

[화학식 3](3)

Figure pat00003
Figure pat00003

(상기 식들에서, R1, R2, R3, R4, R5 및 R6은 각각 독립적으로 수소, -R7-COOH 또는 이들의 염이고, R7은 C1~C5의 지방족, 치환되거나 치환되지 않은 방향족 고리, 또는 복소환 6원자 또는 5원자 고리이다.)Wherein R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are each independently hydrogen, -R 7 -COOH or a salt thereof, R 7 is a C 1 to C 5 aliphatic, A substituted or unsubstituted aromatic ring, or a heterocyclic 6-atom or 5-membered ring.

상기 유효성분은 하기 화학식 1a의 트리엔틴, 화학식 2a의 사이클렌, 화학식 3a의 사이클람 또는 이들의 염 중에서 선택되는 것이 바람직하다.The active ingredient is preferably selected from the group consisting of trienetine of the following general formula (1a), cyclane of the general formula (2a), cyclam of the general formula (3a) or salts thereof.

[화학식 1a][Formula 1a]

Figure pat00004
Figure pat00004

[화학식 2a](2a)

Figure pat00005
Figure pat00005

[화학식 3a][Chemical Formula 3]

Figure pat00006
Figure pat00006

상기 트리엔틴 유도체는 하기 화학식 1b 내지 1d로 표시되는 화합물 또는 이들의 염 중에서 선택되는 것이 바람직하다.The triethyne derivative is preferably selected from compounds represented by the following formulas (1b) to (1d) or salts thereof.

[화학식 1b][Chemical Formula 1b]

Figure pat00007
Figure pat00007

[화학식 1c][Chemical Formula 1c]

Figure pat00008
Figure pat00008

[화학식 1d]≪ RTI ID = 0.0 &

Figure pat00009
Figure pat00009

(상기 식들에서, R8, R9는 각각 독립적으로 수소 또는 C1~C4의 알킬기이고, X는 산소(O), 황(S) 또는 질소(N)이다.)(Wherein R 8 and R 9 are each independently hydrogen or a C 1 -C 4 alkyl group and X is oxygen (O), sulfur (S) or nitrogen (N).)

상기 사이클렌 유도체는 하기 화학식 2b 내지 2d로 표시되는 화합물 또는 이들의 염 중에서 선택되는 것이 바람직하다.The cyclic derivatives are preferably selected from compounds represented by the following formulas (2b) to (2d) or salts thereof.

[화학식 2b](2b)

Figure pat00010
Figure pat00010

[화학식 2c][Chemical Formula 2c]

Figure pat00011
Figure pat00011

[화학식 2d](2d)

Figure pat00012
Figure pat00012

(상기 식들에서, R8, R9는 각각 독립적으로 수소 또는 C1~C4의 알킬기이고, X는 산소(O), 황(S) 또는 질소(N)이다.)(Wherein R 8 and R 9 are each independently hydrogen or a C 1 -C 4 alkyl group and X is oxygen (O), sulfur (S) or nitrogen (N).)

상기 사이클람 유도체는 하기 화학식 3b 내지 3d로 표시되는 화합물 또는 이들의 염 중에서 선택되는 것이 바람직하다.The cyclic derivative is preferably selected from compounds represented by the following formulas (3b) to (3d) or salts thereof.

[화학식 3b](3b)

Figure pat00013
Figure pat00013

[화학식 3c][Chemical Formula 3c]

Figure pat00014
Figure pat00014

[화학식 3d](3d)

Figure pat00015
Figure pat00015

(상기 식들에서, R8, R9는 각각 독립적으로 수소 또는 C1~C4의 알킬기이고, X는 산소(O), 황(S) 또는 질소(N)이다.)(Wherein R 8 and R 9 are each independently hydrogen or a C 1 -C 4 alkyl group and X is oxygen (O), sulfur (S) or nitrogen (N).)

본 발명에 따른 유효성분을 함유하는 필터는 미세먼지에 존재하는 중금속을 제거하는 데 효과가 탁월하여, 공기청정기, 에어컨, 공기순환시스템 등 각종 공조장치에 이용될 수 있는 공기 필터, 담배 필터, 공기 마스크 소재로 유용하게 이용될 수 있다.The filter containing the active ingredient according to the present invention is excellent in the removal of heavy metals present in fine dust, and is excellent in an air filter, a cigarette filter, and an air filter which can be used in various air conditioners such as an air purifier, an air conditioner, And can be usefully used as a mask material.

본 발명에 있어서, "필터"는 공기청정기, 에어컨, 공기순환시스템 등 각종 공조장치에 이용될 수 있는 공기 필터는 물론 담배 필터, 공기 마스크용 필터를 포함한다.In the present invention, the term " filter " includes an air filter that can be used in various air conditioners such as an air purifier, an air conditioner, and an air circulation system, as well as a filter for a cigarette filter and an air mask.

본 발명자들은 중금속과 1급 발암 물질인 포름알데히드를 효과적으로 제거할 수 있는 필터 소재를 개발하기 위하여 중금속 킬레이트제에 대해 다양한 연구를 수행하였고, 현재 의약품으로 이용되고 있는 트리엔틴, 사이클렌, 사이클람과 이들의 유도체를 필터의 중금속, 포름알데히드 흡착제로 이용시 그 제거능이 현저히 우수수한 것으로 확인하여 본 발명에 이르렀다.The present inventors have conducted various studies on heavy metal chelating agents in order to develop a filter material capable of effectively removing heavy metals and formaldehyde as a first-level carcinogen, and have found that trienetine, acycene, cyclam And derivatives thereof as a heavy metal and formaldehyde adsorbent of the filter, the present invention has been accomplished.

트리엔틴(trientine)은 하기 화학식 1a로 표시되며, Triethylenetetramine(TETA)로 명칭된다.Trientine is represented by the following formula (1a) and is named Triethylenetetramine (TETA).

[화학식 1a][Formula 1a]

Figure pat00016
Figure pat00016

트리엔틴 중염산염(Triethylenetetramine dihydrochloride)는 생쥐실험에서 구리(copper)의 대사에 관여하는 것이 밝혀졌으며(F. W. Sunderman et al., Toxicol. Appl. Pharmacol. 38, 177 (1976)), 약리적으로는 구리에 대한 킬레이트제로 작용하여 윌슨병(Wilson's disease) 치료제로 잘 알려져 있다(J. M. Walshe, Prog. Clin. Biol. Res. 34, 271 (1979); R. H. Haslam et al., Dev. Pharmacol. Ther. 1, 318 (1980)).Triethylenetetramine dihydrochloride has been shown to participate in the metabolism of copper in mouse experiments (FW Sunderman et al., Toxicol. Appl. Pharmacol . 38, 177 (1976)), pharmacologically, copper (JM Walshe, Prog. Clin. Biol . Res. 34, 271 (1979); RH Haslam et al., Dev. Pharmacol. Ther . 318 (1980)).

사이클렌(Cyclen)은 하기 화학식 2a로 표시되는 1,4,7,10-tetraazacyclododecane의 일반명으로, 가돌리늄(Gd)과 배위결합을 통해 킬레이트를 형성하여 핵의학 조영제 등에 이용되고 있다.Cyclen is a generic name of 1,4,7,10-tetraazacyclododecane represented by the following formula (2a), which forms a chelate through coordination bond with gadolinium (Gd) and is used as a nuclear medicine contrast agent.

[화학식 2a](2a)

Figure pat00017
Figure pat00017

사이클람(Cyclam)은 하기 화학식 3a로 표시되는 1,4,8,11-tetraazacyclotetradecane의 일반명으로 핵의학 조영제 등에 이용되고 있다.Cyclam is a general name of 1,4,8,11-tetraazacyclotetradecane represented by the following formula (3a), and is used for nuclear medicine contrast agents and the like.

[화학식 3a][Chemical Formula 3]

Figure pat00018
Figure pat00018

상기 트리엔틴, 사이클렌, 사이클람과 같은 킬레이트제들은 경구 또는 혈관 투여 방법을 통하여 체내의 구리 배출하거나 조영제 재료로서의 의약적 용도는 잘 알려져 있으나, 필터 재료로의 용도 연구는 보고된 바 없다.The chelating agents such as trienetine, cyclamen, and cyclam are widely known to be used for oral administration or vascular administration of copper or for pharmaceutical use as a contrast agent, but no studies have been reported on their use as filter materials.

본 발명에 이르러 트리엔틴, 사이클렌, 사이클람 화합물이 중금속 제거를 위한 필터 성분으로 유용함이 확인되었다. 본 발명에서 필터 소재로서 미세먼지 속 중금속 제거능과 피부 자극, 독성에 대한 결과가 개시된다. 트리엔틴, 사이클렌, 사이클람 화합물은 종래 피부에 유해한 것으로 알려져 있으나, 본 발명의 실험 결과 피부 상의 중금속 제거에 효과적인 양의 사용에서는 피부 자극 또는 독성이 없거나 필터 재료로서 허용될 수 있는 정도로 매우 낮은 것이 확인되었다.The present inventors have found that trien- tine, acycene, and cyclam compounds are useful as filter components for removing heavy metals. As a filter material in the present invention, results of removing heavy metals in fine dust, skin irritation, and toxicity are disclosed. The trienetine, cyclamen and cyclam compounds are known to be harmful to the skin in the past. As a result of the experiments of the present invention, it has been found that the use of an effective amount for removing heavy metals on the skin results in no skin irritation or toxicity, .

한편, 본 발명에 이르러 트리엔틴, 사이클렌, 사이클람과 이들의 유도체 화합물이 1급 발암물질인 포름알데히드의 제거에 매우 효과적인 것이 확인되었다.On the other hand, it has been confirmed by the present invention that trien- tine, cyclane, cyclam and their derivative compounds are highly effective for the removal of formaldehyde as a primary carcinogen.

본 발명은 하기 화학식 1로 표시되는 트리엔틴 또는 트리엔틴 유도체, 하기 화학식 2로 표시되는 사이클렌 또는 사이클렌 유도체, 하기 화학식 3으로 표시되는 사이클람 또는 사이클람 유도체 중에서 선택된 1종 이상을 유효성분으로 하는, 중금속 및 포름알데히드 제거능을 가지는 필터를 제공한다.The present invention relates to a triene or triene derivative represented by the following general formula (1), a cyclane or a cyclene derivative represented by the following general formula (2), a cyclam or cyclam derivative represented by the general formula A filter having heavy metal and formaldehyde removing ability.

[화학식 1][Chemical Formula 1]

Figure pat00019
Figure pat00019

[화학식 2](2)

Figure pat00020
Figure pat00020

[화학식 3](3)

Figure pat00021
Figure pat00021

(상기 식들에서, R1, R2, R3, R4, R5 및 R6은 각각 독립적으로 수소, -R7-COOH 또는 이들의 염이고, R7은 C1~C5의 지방족, 치환되거나 치환되지 않은 방향족 고리, 또는 복소환 6원자 또는 5원자 고리이다.)Wherein R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are each independently hydrogen, -R 7 -COOH or a salt thereof, R 7 is a C 1 to C 5 aliphatic, A substituted or unsubstituted aromatic ring, or a heterocyclic 6-atom or 5-membered ring.

본 발명의 공기 필터는 중금속 및 포름알데히드 제거를 위한 유효성분으로 트리엔틴, 사이클렌, 사이클람 또는 이들의 염을 포함하는 것을 특징으로 한다.The air filter of the present invention is characterized in that it contains trientine, cyclane, cyclam or salts thereof as an effective ingredient for removing heavy metals and formaldehyde.

한편, 본 발명에서 상기 트리엔틴, 사이클렌, 사이클람 화합물의 아민 위치에 카르복실기를 도입하여 중금속 배위결합도를 향상시키는 한편, 방향족 또는 복소환기를 도입하는 경우 피부 자극이 현저히 저감되는 것이 확인되었다.On the other hand, in the present invention, it has been confirmed that when a carboxyl group is introduced into the amine position of the trienetine, the cyclane and cyclam compounds to improve the degree of coordination of heavy metal, and the aromatic or heterocyclic group is introduced, skin irritation is remarkably reduced .

본 발명에 따른 트리엔틴 유도체, 사이클렌 유도체, 사이클람 유도체는 하기 화학식 1b 내지 3d로 표시되는 화합물에서 선택되는 것이 바람직하다.The trienetine derivatives, cyclic derivatives and cyclam derivatives according to the present invention are preferably selected from the compounds represented by the following formulas (1b) to (3d).

[화학식 1b][Chemical Formula 1b]

Figure pat00022
Figure pat00022

[화학식 1c][Chemical Formula 1c]

Figure pat00023
Figure pat00023

[화학식 1d]≪ RTI ID = 0.0 &

Figure pat00024
Figure pat00024

[화학식 2b](2b)

Figure pat00025
Figure pat00025

[화학식 2c][Chemical Formula 2c]

Figure pat00026
Figure pat00026

[화학식 2d](2d)

Figure pat00027
Figure pat00027

[화학식 3b](3b)

Figure pat00028
Figure pat00028

[화학식 3c][Chemical Formula 3c]

Figure pat00029
Figure pat00029

[화학식 3d](3d)

Figure pat00030
Figure pat00030

(상기 식들에서, R8, R9는 각각 독립적으로 수소 또는 C1~C4의 알킬기이고, X는 산소(O), 황(S) 또는 질소(N)이다.)(Wherein R 8 and R 9 are each independently hydrogen or a C 1 -C 4 alkyl group and X is oxygen (O), sulfur (S) or nitrogen (N).)

본 발명의 트리엔틴 또는 트리엔틴 유도체, 사이클렌 또는 사이클렌 유도체, 사이클람 또는 사이클람 유도체 화합물은 필터의 용도, 소재에 따라 그 함량은 변경가능하다. 본 발명의 유효성분은 유효성분이 함유된 필터 중량에 대하여 제한되지는 않으나 0.001 ~ 5.0 중량%, 바람직하게는 0.1 ~ 3.0 중량%, 더욱 바람직하게는 0.2 ~ 2.0 중량%로 함유될 수 있다.The content of the trienetine or trientine derivative, cyclane or cyclane derivative, cyclam or cyclam derivative of the present invention can be changed depending on the use of the filter and the material thereof. The active ingredient of the present invention is not limited to the weight of the filter containing the active ingredient but may be contained in an amount of 0.001 to 5.0% by weight, preferably 0.1 to 3.0% by weight, more preferably 0.2 to 2.0% by weight.

본 발명의 트리엔틴 또는 트리엔틴 유도체, 사이클렌 또는 사이클렌 유도체, 사이클람 또는 사이클람 유도체 화합물는 수용성 염의 형태로 이용될 수 있다. 본 발명의 상기 화합물은 염산염, 나트륨염, 칼륨염의 형태를 포함한다. 본 발명의 상기 화합물은 이염산염, 사염산염의 형태인 것이 더욱 바람직하다. 상기 염의 제조는 공지의 방법에 의해 수행될 수 있다.The trienetine or trientine derivatives, cyclans or cyclane derivatives, cyclam or cyclam derivative compounds of the present invention can be used in the form of water-soluble salts. The compounds of the present invention include the hydrochloride salt, the sodium salt, and the potassium salt. More preferably, the compound of the present invention is in the form of a dihydrochloride salt or a tetrachloride salt. The preparation of the salt can be carried out by a known method.

본 발명의 필터는 상기 유효성분을 수용액 또는 용액 형태로 제조하고, 종래 이용되는 필터 소재에 함침시키거나, 스프레이 방식으로 분사시킨 후 건조하는 방식으로 제조될 수 있다. 본 발명의 필터 소재는 종이 필터, 부직포 필터, 섬유 필터, 염화비닐 필터, 헤파(HEPA)필터, 카본, 활성탄, 제오라이트, 실리카겔, 알루미나, 산화제2철 등 각종 흡착제가 첨가된 필터 소재 등 통상적으로 사용되는 필터 소재일 수 있다.The filter of the present invention can be produced by preparing the active ingredient in the form of an aqueous solution or a solution, impregnating the filter material with a conventionally used filter material, or spraying it with a spraying method followed by drying. The filter material of the present invention is generally used for filter materials to which various adsorbents such as paper filters, nonwoven filters, fiber filters, vinyl chloride filters, HEPA filters, carbon, activated carbon, zeolite, silica gel, alumina, Lt; / RTI > filter material.

본 발명의 필터는 단일 필터로 이용될 수 있으며, 다른 필터 소재와 겹친 형태의 복합 필터로 이용될 수 있다.The filter of the present invention can be used as a single filter and can be used as a composite filter in a form overlapped with other filter materials.

이하 실시예를 통하여 본 발명의 중금속 및 포름알데히드 제거능을 가지는 필터를 상세히 설명한다. 다만, 하기 실시예는 본 발명의 일 예시일 뿐 하기 실시예로 본 발명의 청구범위가 제한되지는 않는다.Hereinafter, the filter having the heavy metal and formaldehyde removing ability of the present invention will be described in detail through examples. However, the following examples are only illustrative of the present invention and are not intended to limit the scope of the present invention.

<트리엔틴 유도체의 합성>&Lt; Synthesis of trientine derivative >

실시예 1: 3,6,9,12-tetrakis(carboxymethyl)-3,6,9,12-tetraazatetradecanedioic acid (화학식 1e)의 제조Example 1: Preparation of 3,6,9,12-tetrakis (carboxymethyl) -3,6,9,12-tetraazatetradecanedioic acid (Formula 1e)

Figure pat00031
Figure pat00031

Triethylenetetramine 10.0g과 아세토니트릴(ACN) 400.0ml를 투입 교반하고 K2CO3 66.1g과 Ethyl bromoacetate 78.8g을 투입하고 승온하여 48시간 환류교반하여 반응을 종결한다. 상온으로 냉각하여 여과하여 고체는 폐기하고 여액은 진공 농축한다. 농축액에 메틸렌 클로라이드(MC) 200ml, 정제수 300ml 투입후 30분간 교반후 정치하여 층분리한다. 유기층은 MgSO4 처리하여 진공 농축 후 MC-MeOH로 컬럼정제하여 Diethyl 3,6,9,12-tetrakis(2-ethoxy-2-oxoethyl)-3,6,9,12-tetraazatetradecanedioate 29.6g을 수득하였다.(수율: 64.8%)Triethylenetetramine (10.0 g) and acetonitrile (ACN) (400.0 ml) were added and stirred. 66.1 g of K 2 CO 3 and 78.8 g of ethyl bromoacetate were added. The mixture was heated and refluxed for 48 hours to terminate the reaction. After cooling to room temperature, the solid is discarded by filtration and the filtrate is concentrated in vacuo. Add 200 ml of methylene chloride (MC) and 300 ml of purified water to the concentrate, stir for 30 minutes, and separate into layers. The organic layer was treated with MgSO 4, concentrated in vacuo and then subjected to column purification using MC-MeOH to obtain 29.6 g of diethyl 3,6,9,12-tetrakis (2-ethoxy-2-oxoethyl) -3,6,9,12-tetraazatetradecanedioate . (Yield: 64.8%)

1H NMR (CDCl3): 4.16(q, 8H), 4.14(q, 4H), 3.57(s, 8H), 3.44(s, 4H), 2.85(t, 4H), 2.78(t, 4H), 2.74(s, 4H), 1.27(t, 12H), 1.26(t, 6H) 1 H NMR (CDCl 3): 4.16 (q, 8H), 4.14 (q, 4H), 3.57 (s, 8H), 3.44 (s, 4H), 2.85 (t, 4H), 2.78 (t, 4H), 2.74 (s, 4H), 1.27 (t, 12H), 1.26 (t, 6H)

상기 제조된 Diethyl 3,6,9,12-tetrakis(2-ethoxy-2-oxoethyl)-3,6,9,12-tetraazatetradecanedioate 29.6g과 NaOH 12.33g, MeOH 180ml, 정제수 120ml를 투입하고 55~60℃로 승온하여 12시간 교반하여 반응을 종결한다. 40℃로 냉각하고 진공 농축하여 용매를 제거하고 10% HCl 수용액으로 pH를 5~6로 맞추고 30분간 교반한다. MC 400ml를 투입하여 추출한다. 추출한 유기층은 MgSO4 처리하여 표제 화합물 15.9g을 수득하였다.(수율: 72.3.0%)29.6 g of the prepared diethyl 3,6,9,12-tetrakis (2-ethoxy-2-oxoethyl) -3,6,9,12-tetraazatetradecanedioate, 12.33 g of NaOH, 180 ml of MeOH and 120 ml of purified water, Lt; 0 &gt; C and stirred for 12 hours to terminate the reaction. Cool to 40 &lt; 0 &gt; C and concentrate in vacuo to remove the solvent, adjust the pH to 5-6 with 10% aqueous HCl and stir for 30 min. Add 400 ml of MC to extract. The extracted organic layer was treated with MgSO 4 to obtain 15.9 g of the title compound (Yield: 72.3.0%).

1H NMR (DMSO): 4.57(s, 8H), 4.55(s, 4H), 4.22(s, 12H) 1 H NMR (DMSO): 4.57 (s, 8H), 4.55 (s, 4H), 4.22 (s, 12H)

실시예 2: 4,4',4'',4'''-(((ethane-1,2-diylbis((4-carboxyphenyl)azanediyl))bis(ethane-2,1-diyl))bis(azanetriyl))tetrabenzoic acid (화학식 1f)의 제조Example 2: Preparation of 4,4 ', 4 ", 4"' - (((ethane-1,2-diylbis ((4- carboxyphenyl) azanediyl) azanetriyl)) &lt; / RTI &gt; tetrabenzoic acid (1f)

Figure pat00032
Figure pat00032

트리에틸렌테트라민 10.0g, ethyl 4-bromobenzoate 108,1g, t-BuONa 46.0g과 toluene 600ml를 투입 교반한다. 35℃로 승온하여 50% (t-Bu)3P toluene solution 2.8g을 투입하고 30분간 교반하고 50℃로 승온한 후 Pd(dba)2 2.0g을 투입하고 승온하여 환류교반하여 반응을 종결한다. 상온으로 냉각하여 정제수 1000ml를 투입하고 30분간 교반 정치하여 층분리하여 수층은 폐기한다. 유기층은 MgSO4 처리하여 진공 농축 후 MC-MeOH 컬럼 정제하여 tetraethyl 4,4',4'',4'''-(((ethane-1,2-diylbis((4-(ethoxycarbonyl)phenyl)azanediyl)) bis(ethane-2,1-diyl))bis(azanetriyl))tetrabenzoate 22.9g을 수득 하였다. (수율: 32.4%)10.0 g of triethylenetetramine, 108.1 g of ethyl 4-bromobenzoate, 46.0 g of t-BuONa and 600 ml of toluene are stirred and stirred. The temperature was raised to 35 ° C and 2.8 g of 50% (t-Bu) 3 P toluene solution was added. After stirring for 30 minutes, the temperature was raised to 50 ° C. and 2.0 g of Pd (dba) 2 was added. . After cooling to room temperature, 1000 ml of purified water is added, and the mixture is left to stand for 30 minutes to separate the layers, and the aqueous layer is discarded. The organic layer was treated with MgSO 4, concentrated in vacuo and purified by MC-MeOH column to obtain tetraethyl 4,4 ', 4'',4''- (((ethane-1,2-diylbis (4- (ethoxycarbonyl) phenyl) azanediyl )) bis (ethane-2,1-diyl)) bis (azanetriyl)) tetrabenzoate. (Yield: 32.4%)

1H NMR (CDCl3): 7.82(m, 4H), 7.71(m, 8H), 7.25(m, 8H), 6.95(m, 4H), 4.15(q, 8H), 4.11(q, 4H), 3.45~3.18(m, 12H), 1.27(t, 12H), 1.26(t, 6H) 1 H NMR (CDCl 3 ): 7.82 (m, 4H), 7.71 (m, 8H), 7.25 (m, 8H) 3.45 ~ 3.18 (m, 12H), 1.27 (t, 12H), 1.26 (t, 6H)

tetraethyl 4,4',4'',4'''-(((ethane-1,2-diylbis((4-(ethoxycarbonyl)phenyl)azanediyl)) bis(ethane-2,1-diyl))bis(azanetriyl))tetrabenzoate 22.9g과 NaOH 6.1g, MeOH 180ml, 정제수 140ml를 투입하고 55~60℃로 승온하여 12시간 교반하여 반응을 종결한다. 40℃로 냉각하고 진공 농축하여 용매를 제거하고 10% HCl 수용액으로 pH를 5~6로 맞추고 30분간 교반한다. MC 200ml를 투입하여 추출한다. 추출한 유기층은 MgSO4 처리하여 표제 화합물 17.0g을 수득하였다. (수율: 89.0%)bis (ethane-2,1-diyl) bis ((4-ethoxycarbonyl) phenyl) azethenyl) azanetriyl)) tetrabenzoate, 6.1 g of NaOH, 180 ml of MeOH and 140 ml of purified water were charged, the temperature was raised to 55 to 60 ° C and the reaction was terminated by stirring for 12 hours. Cool to 40 &lt; 0 &gt; C and concentrate in vacuo to remove the solvent, adjust the pH to 5-6 with 10% aqueous HCl and stir for 30 min. 200 ml of MC is added to extract. The extracted organic layer was treated with MgSO 4 to obtain 17.0 g of the title compound. (Yield: 89.0%).

1H NMR (DMSO): 7.80(m, 4H), 7.68(m, 8H), 7.15(m, 8H), 6.94(m, 4H), 3.41~3.28(m, 12H) 1 H NMR (DMSO): 7.80 (m, 4H), 7.68 (m, 8H)

실시예 3: 5,5'-((2-((5-carboxypyridin-3-yl)(2-((5-carboxypyridin-3-yl)(2-((5-carboxypyridin-3-yl)(2-carboxypyridin-4-yl)amino)ethyl)amino)ethyl)amino)ethyl)azanediyl)dinicotinic acid (화학식 1g)의 제조Example 3: Synthesis of 5,5 '- ((2 - ((5-carboxypyridin-3-yl) 2-carboxypyridin-4-yl) amino) ethyl) amino) ethyl) amino) ethyl) azanediyl) dinicotinic acid (Formula 1g)

Figure pat00033
Figure pat00033

Triethylenetetramine 10.0g, ethyl 5-bromonicotinate 108,5g, t-BuONa 46.0g과 Xylene 600ml를 투입 교반한다. 35℃로 승온하여 50% (t-Bu)3P toluene solution 2.8g을 투입하고 30분간 교반하고 50℃로 승온한 후 Pd(dba)2 2.0g을 투입하고 승온하여 환류교반하여 반응을 종결한다. 상온으로 냉각하여 정제수 1000ml를 투입하고 30분간 교반 정치하여 층분리하여 수층은 폐기한다. 유기층은 MgSO4 처리하여 진공 농축 후 MC-MeOH 컬럼 정제하여 diethyl 5,5'-((2-((5-(ethoxycarbonyl)pyridin-3-yl)(2-((5-(ethoxycarbonyl)pyridin-3-yl)(2-((5-(ethoxycarbonyl)pyridin-3-yl)(2-(ethoxycarbonyl)pyridin-4-yl)amino)ethyl)amino)ethyl)amino)ethyl)azanediyl)dinicotinate 19.8g을 수득 하였다. (수율: 27.8%)10.0 g of triethylenetetramine, 108.5 g of ethyl 5-bromonicotinate, 46.0 g of t-BuONa and 600 ml of xylene are added and stirred. The temperature was raised to 35 ° C and 2.8 g of 50% (t-Bu) 3 P toluene solution was added. After stirring for 30 minutes, the temperature was raised to 50 ° C. and 2.0 g of Pd (dba) 2 was added. . After cooling to room temperature, 1000 ml of purified water is added, and the mixture is left to stand for 30 minutes to separate the layers, and the aqueous layer is discarded. The organic layer was treated with MgSO 4, concentrated in vacuo and purified by MC-MeOH column to obtain diethyl 5,5 '- ((2- ((5- (ethoxycarbonyl) pyridin- Pyridin-4-yl) amino) ethyl) amino) ethyl) amino) ethyl) azanediyl) dinicotinate . (Yield: 27.8%)

1H NMR (CDCl3): 8.92(d, 4H), 8.85(d, 2H), 8.45(d, 4H), 8.43(d, 2H), 7.89(d, 4H), 7.76(d, 2H), 4.23(q, 8H), 4.15(q, 4H), 3.42~3.11(m, 12H), 1.27(t, 12H), 1.26(t, 6H) 1 H NMR (CDCl 3): 8.92 (d, 4H), 8.85 (d, 2H), 8.45 (d, 4H), 8.43 (d, 2H), 7.89 (d, 4H), 7.76 (d, 2H), 12H), 1.26 (t, 6H), 4.23 (q, 8H), 4.15

diethyl 5,5'-((2-((5-(ethoxycarbonyl)pyridin-3-yl)(2-((5-(ethoxycarbonyl)pyridin 3-yl)(2-((5-(ethoxycarbonyl)pyridin-3-yl)(2-(ethoxycarbonyl)pyridin-4-yl)amino)ethyl)amino)ethyl)amino)ethyl)azanediyl)dinicotinate 19.8g과 NaOH 5.3g, MeOH 160ml, 정제수 120ml를 투입하고 55~60℃로 승온하여 12시간 교반하여 반응을 종결한다. 40℃로 냉각하고 진공 농축하여 용매를 제거하고 10% HCl 수용액으로 pH를 5~6로 맞추고 30분간 교반한다. MC 160ml를 투입하여 추출한다. 추출한 유기층은 MgSO4 처리하여 표제 화합물 13.0g을 수득하였다. (수율: 78.4%)pyridin-3-yl) (2 - ((5- (ethoxycarbonyl) pyridin-3-yl) (2- (5- (ethoxycarbonyl) pyridin- Amino) ethyl) azanediyl) dinicotinate, 5.3 g of NaOH, 160 ml of MeOH and 120 ml of purified water were charged, and the mixture was stirred at 55 to 60 ° C And the mixture was stirred for 12 hours to terminate the reaction. Cool to 40 &lt; 0 &gt; C and concentrate in vacuo to remove the solvent, adjust the pH to 5-6 with 10% aqueous HCl and stir for 30 min. Add 160 ml of MC to extract. The extracted organic layer was treated with MgSO 4 to obtain 13.0 g of the title compound. (Yield: 78.4%).

1H NMR (DMSO): 8.95(d, 4H), 8.87(d, 2H), 8.46(d, 4H), 8.44(d, 2H), 7.89(d, 4H), 7.75(d, 2H), 3.41~3.11(m, 12H) 1 H NMR (DMSO): 8.95 (d, 4H), 8.87 (d, 2H), 8.46 (d, 4H), 8.44 (d, 2H), 7.89 (d, 4H), 7.75 (d, 2H), 3.41 ~ 3.11 (m, 12H)

실시예 4: 5,5',5'',5'''-(((ethane-1,2-diylbis((5-carboxyfuran-2-yl)azanediyl))bis(ethane-2,1-diyl))bis(azanetriyl))tetrakis(furan-2-carboxylic acid) (화학식 1h)의 제조Example 4: Synthesis of 5,5 ', 5' ', 5 "' - (((ethane-1,2-diylbis (5-carboxyfuran- )) bis (azanetriyl)) tetrakis (furan-2-carboxylic acid)

Figure pat00034
Figure pat00034

Triethylenetetramine 10.0g, ethyl 5-bromofuran-2-carboxylate 103,3g, t-BuONa 46.0g과 toluene 600ml를 투입 교반한다. 35℃로 승온하여 50% (t-Bu)3P toluene solution 2.8g을 투입하고 30분간 교반하고 50℃로 승온한 후 Pd(dba)2 2.0g을 투입하고 승온하여 환류교반하여 반응을 종결한다. 상온으로 냉각하여 정제수 1000ml를 투입하고 30분간 교반 정치하여 층분리하여 수층은 폐기한다. 유기층은 MgSO4 처리하여 진공 농축 후 MC-MeOH 컬럼 정제하여 tetraethyl 5,5',5'',5'''-(((ethane-1,2-diylbis((5-(ethoxycarbonyl)furan-2-yl)azanediyl))bis(ethane-2,1-diyl))bis(azanetriyl))tetrakis(furan-2-carboxylate) 25.3g을 수득 하였다. (수율: 37.9%)10.0 g of triethylenetetramine, 103.3 g of ethyl 5-bromofuran-2-carboxylate, 46.0 g of t-BuONa and 600 ml of toluene are added and stirred. The temperature was raised to 35 ° C and 2.8 g of 50% (t-Bu) 3 P toluene solution was added. After stirring for 30 minutes, the temperature was raised to 50 ° C. and 2.0 g of Pd (dba) 2 was added. . After cooling to room temperature, 1000 ml of purified water is added, and the mixture is left to stand for 30 minutes to separate the layers, and the aqueous layer is discarded. The organic layer was treated with MgSO 4, concentrated in vacuo and purified by MC-MeOH column to obtain tetraethyl 5,5 ', 5'',5''' - (((ethane-1,2-diylbis (5- (ethoxycarbonyl) furan- -yl) azanediyl) bis (ethane-2,1-diyl)) bis (azanetriyl)) tetrakis (furan-2-carboxylate). (Yield: 37.9%).

1H NMR (CDCl3): 7.42(m, 12H), 4.31(q, 8H), 4.28(q, 4H), 3.65~3.15(m, 12H), 1.27(t, 12H), 1.25(t, 6H) 1 H NMR (CDCl 3 ): 7.42 (m, 12H), 4.31 (q, 8H), 4.28 (q, 4H), 3.65-3.15 )

tetraethyl 5,5',5'',5'''-(((ethane-1,2-diylbis((5-(ethoxycarbonyl)furan-2-yl)azanediyl))bis (ethane-2,1-diyl))bis(azanetriyl))tetrakis(furan-2-carboxylate) 25.3g과 NaOH 7.2g, MeOH 200ml, 정제수 150ml를 투입하고 55~60℃로 승온하여 12시간 교반하여 반응을 종결한다. 40℃로 냉각하고 진공 농축하여 용매를 제거하고 10% HCl 수용액으로 pH를 5~6로 맞추고 30분간 교반한다. MC 200ml를 투입하여 추출한다. 추출한 유기층은 MgSO4 처리하여 표제 화합물 15.0g을 수득하였다. (수율: 71.8%)(ethane-1,2-diylbis (5- (ethoxycarbonyl) furan-2-yl) azanediyl) bis (ethane-2,1-diyl )) bis (azanetriyl)) tetrakis (furan-2-carboxylate), 7.2 g of NaOH, 200 ml of MeOH and 150 ml of purified water were charged and the mixture was heated to 55 to 60 ° C and stirred for 12 hours. Cool to 40 &lt; 0 &gt; C and concentrate in vacuo to remove the solvent, adjust the pH to 5-6 with 10% aqueous HCl and stir for 30 min. 200 ml of MC is added to extract. The extracted organic layer was treated with MgSO 4 to obtain 15.0 g of the title compound. (Yield: 71.8%)

1H NMR (DMSO): 7.41(m, 12H), 3.67~3.15(m, 12H) 1 H NMR (DMSO): 7.41 (m, 12H), 3.67-3.15 (m, 12H)

<사이클렌 유도체의 합성>&Lt; Synthesis of cyclic derivatives &

실시예 5: 2,2',2'',2'''-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetic acid (화학식 2e)의 제조Example 5: Preparation of 2,2 ', 2 ", 2' '- (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl) tetraacetic acid (Formula 2e)

Figure pat00035
Figure pat00035

Cyclen 10.0g과 acetonitrile 400.0ml를 투입 교반하고 K2CO3 40.1g과 Ethyl bromoacetate 42.7g을 투입하고 승온하여 40시간 환류교반하여 반응을 종결한다. 상온으로 냉각하여 여과하여 고체는 폐기하고 여액은 진공 농축한다. 농축액에 MC 200ml, 정제수 300ml 투입후 30분간 교반후 정치하여 층분리한다. 유기층은 MgSO4 처리하여 진공 농축 후 MC-MeOH로 컬럼정제하여 tetraethyl 2,2',2'',2'''-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetate 15.7g을 수득하였다.(수율: 52.3%)10.0 g of Cyclen and 400.0 ml of acetonitrile are added and stirred, 40.1 g of K 2 CO 3 and 42.7 g of ethyl bromoacetate are added, and the mixture is heated to reflux for 40 hours to complete the reaction. After cooling to room temperature, the solid is discarded by filtration and the filtrate is concentrated in vacuo. Add 200 ml of MC and 300 ml of purified water to the concentrate, stir for 30 minutes, and separate. The organic layer was dried over MgSO 4, concentrated in vacuo and column-purified with MC-MeOH to give tetraethyl 2,2 ', 2'',2''' - (1,4,7,10-tetraazacyclododecane- tetrayl) tetraacetate (yield: 52.3%).

1H NMR (CDCl3): 4.19(q, 8H), 3.19(s, 8H), 2.48(s, 16H), 1.27(t, 12H) 1 H NMR (CDCl 3 ): 4.19 (q, 8H), 3.19 (s, 8H), 2.48

tetraethyl 2,2',2'',2'''-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetate 15.7g과 NaOH 5.6g, MeOH 95ml, 정제수 60ml를 투입하고 55~60℃로 승온하여 12시간 교반하여 반응을 종결한다. 40℃로 냉각하고 진공 농축하여 용매를 제거하고 10% HCl 수용액으로 pH를 5~6로 맞추고 30분간 교반한다. MC 200ml를 투입하여 추출한다. 추출한 유기층은 MgSO4 처리하여 표제 화합물 9.9g을 수득하였다. (수율: 80.5%)15.7 g of tetraethyl 2,2 ', 2'',2''- (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl) tetraacetate, 5.6 g of NaOH, 95 ml of MeOH, The mixture was heated to 55 to 60 ° C and stirred for 12 hours to terminate the reaction. Cool to 40 &lt; 0 &gt; C and concentrate in vacuo to remove the solvent, adjust the pH to 5-6 with 10% aqueous HCl and stir for 30 min. 200 ml of MC is added to extract. The organic layer was extracted to give the title compound, 9.9g MgSO 4 and treated. (Yield: 80.5%).

1H NMR (DMSO): 3.88(s, 8H), 3.23(s, 16H) 1 H NMR (DMSO): 3.88 (s, 8H), 3.23 (s, 16H)

실시예 6: 4,4',4'',4'''-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl)tetrabenzoic acid (화학식 2f)의 제조Example 6: Preparation of 4,4 ', 4 ", 4"' - (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl) tetrabenzoic acid (2f)

Figure pat00036
Figure pat00036

Cyclen 10.0g, ethyl 4-bromobenzoate 58.5g, t-BuONa 27.9g과 toluene 400ml를 투입 교반한다. 35℃로 승온하여 50% (t-Bu)3P toluene solution 2.4g을 투입하고 30분간 교반하고 50℃로 승온한 후 Pd(dba)2 1.7g을 투입하고 승온하여 환류교반하여 반응을 종결한다. 상온으로 냉각하여 정제수 1000ml를 투입하고 30분간 교반 정치하여 층분리하여 수층은 폐기한다. 유기층은 MgSO4 처리하여 진공 농축 후 MC-MeOH 컬럼 정제하여 tetraethyl 4,4',4'',4'''-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl)tetrabenzoate 15.8g을 수득 하였다. (수율: 35.6%)Cyclen, 58.5 g of ethyl 4-bromobenzoate, 27.9 g of t-BuONa, and 400 ml of toluene are stirred. 2.4 g of 50% (t-Bu) 3 P toluene solution was added to the mixture, and the mixture was stirred for 30 minutes. After heating to 50 ° C, 1.7 g of Pd (dba) 2 was added and the mixture was heated to reflux . After cooling to room temperature, 1000 ml of purified water is added, and the mixture is left to stand for 30 minutes to separate the layers, and the aqueous layer is discarded. The organic layer was dried over MgSO 4, concentrated in vacuo, and purified by MC-MeOH column to obtain tetraethyl 4,4 ', 4'',4''' - (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl ) tetrabenzoate. &lt; / RTI &gt; (Yield: 35.6%).

1H NMR (CDCl3): 7.81(d, 8H), 6.98(d, 8H), 4,15(q, 8H), 3.48(s, 16H), 1,25(t, 12H) 1 H NMR (CDCl 3 ): 7.81 (d, 8H), 6.98 (d, 8H), 4,15 (q, 8H)

tetraethyl 4,4',4'',4'''-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl)tetrabenzoate 15.8g과 NaOH 3.8g, MeOH 130ml, 정제수 100ml를 투입하고 55~60℃로 승온하여 12시간 교반하여 반응을 종결한다. 40℃로 냉각하고 진공 농축하여 용매를 제거하고 10% HCl 수용액으로 pH를 5~6로 맞추고 30분간 교반한다. MC 130ml를 투입하여 추출한다. 추출한 유기층은 MgSO4 처리하여 표제 화합물 11.5g을 수득하였다. (수율: 85.2%)15.8 g of tetraethyl 4,4 ', 4'',4''- (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl) tetrabenzoate, 3.8 g of NaOH, 130 ml of MeOH, The mixture was heated to 55 to 60 ° C and stirred for 12 hours to terminate the reaction. Cool to 40 &lt; 0 &gt; C and concentrate in vacuo to remove the solvent, adjust the pH to 5-6 with 10% aqueous HCl and stir for 30 min. Add 130 ml of MC to extract. The extracted organic layer was treated with MgSO 4 to obtain 11.5 g of the title compound. (Yield: 85.2%).

1H NMR (DMSO): 7.82(d, 8H), 6.97(d, 8H), 3.45(s, 16H) 1 H NMR (DMSO): 7.82 (d, 8H), 6.97 (d, 8H), 3.45

실시예 7: 5,5',5'',5'''-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl)tetranicotinic acid (화학식 2g)의 제조Example 7: Preparation of 5,5 ', 5 ", 5"' - (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl) tetranicotinic acid (Formula 2g)

Figure pat00037
Figure pat00037

Cyclen 10.0g, ethyl 5-bromonicotinate 58.7g, t-BuONa 27.9g과 xylene 400ml를 투입 교반한다. 35℃로 승온하여 50% (t-Bu)3P toluene solution 2.4g을 투입하고 30분간 교반하고 50℃로 승온한 후 Pd(dba)2 1.7g을 투입하고 승온하여 환류교반하여 반응을 종결한다. 상온으로 냉각하여 정제수 1000ml를 투입하고 30분간 교반 정치하여 층분리하여 수층은 폐기한다. 유기층은 MgSO4 처리하여 진공 농축 후 MC-MeOH 컬럼 정제하여 tetraethyl 5,5',5'',5'''-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl)tetranicotinate 17.9g을 수득 하였다. (수율: 40.1%)Cyclen, 58.7 g of ethyl 5-bromonicotinate, 27.9 g of t-BuONa, and 400 ml of xylene are added and stirred. 2.4 g of 50% (t-Bu) 3 P toluene solution was added to the mixture, and the mixture was stirred for 30 minutes. After heating to 50 ° C, 1.7 g of Pd (dba) 2 was added and the mixture was heated to reflux . After cooling to room temperature, 1000 ml of purified water is added, and the mixture is left to stand for 30 minutes to separate the layers, and the aqueous layer is discarded. The organic layer was dried over MgSO 4, concentrated in vacuo and purified by MC-MeOH column to obtain tetraethyl 5,5 ', 5'',5''- (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl ) tetranicotinate. (Yield: 40.1%).

1H NMR (CDCl3): 8.95(d, 4H), 8.46(d, 4H), 7.83(d, 4H), 4,21(q, 8H), 3.38(s, 16H), 1,24(t, 12H) 1 H NMR (CDCl 3 ): 8.95 (d, 4H), 8.46 (d, 4H), 7.83 , 12H)

tetraethyl 5,5',5'',5'''-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl)tetranicotinate 17.9g과 NaOH 4.3g, MeOH 150ml, 정제수 110ml를 투입하고 55~60℃로 승온하여 12시간 교반하여 반응을 종결한다. 40℃로 냉각하고 진공 농축하여 용매를 제거하고 10% HCl 수용액으로 pH를 5~6로 맞추고 30분간 교반한다. MC 160ml를 투입하여 추출한다. 추출한 유기층은 MgSO4 처리하여 표제 화합물 11.6g을 수득하였다. (수율: 75.6%)17.9 g of tetraethyl 5,5 ', 5'',5''' - (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl) tetranicotinate, 4.3 g of NaOH, 150 ml of MeOH, The mixture was heated to 55 to 60 ° C and stirred for 12 hours to terminate the reaction. Cool to 40 &lt; 0 &gt; C and concentrate in vacuo to remove the solvent, adjust the pH to 5-6 with 10% aqueous HCl and stir for 30 min. Add 160 ml of MC to extract. The extracted organic layer was treated with MgSO 4 to obtain 11.6 g of the title compound. (Yield: 75.6%).

1H NMR (DMSO): 8.96(d, 4H), 8.44(d, 4H), 7.84(d, 4H), 3.36(s, 16H) 1 H NMR (DMSO): 8.96 (d, 4H), 8.44 (d, 4H), 7.84

실시예 8: 5,5',5'',5'''-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl)tetrakis(furan-2-carboxylic acid) (화학식 2h)의 제조Example 8: Synthesis of 5,5 ', 5 "', 5" '- (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl) tetrakis (furan- 2h)

Figure pat00038
Figure pat00038

Cyclen 10.0g, ethyl 5-bromofuran-2-carboxylate 56.0g, t-BuONa 27.9g과 toluene 400ml를 투입 교반한다. 35℃로 승온하여 50% (t-Bu)3P toluene solution 2.4g을 투입하고 30분간 교반하고 50℃로 승온한 후 Pd(dba)2 1.7g을 투입하고 승온하여 환류교반하여 반응을 종결한다. 상온으로 냉각하여 정제수 1000ml를 투입하고 30분간 교반 정치하여 층분리하여 수층은 폐기한다. 유기층은 MgSO4 처리하여 진공 농축 후 MC-MeOH 컬럼 정제하여 tetraethyl 5,5',5'',5'''-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl)tetrakis(furan-2-carboxylate) 12.6g을 수득 하였다. (수율: 30.0%)Cyclen, 56.0 g of ethyl 5-bromofuran-2-carboxylate, 27.9 g of t-BuONa and 400 ml of toluene. 2.4 g of 50% (t-Bu) 3 P toluene solution was added to the mixture, and the mixture was stirred for 30 minutes. After heating to 50 ° C, 1.7 g of Pd (dba) 2 was added and the mixture was heated to reflux . After cooling to room temperature, 1000 ml of purified water is added, and the mixture is left to stand for 30 minutes to separate the layers, and the aqueous layer is discarded. The organic layer was dried over MgSO 4, concentrated in vacuo and purified by MC-MeOH column to obtain tetraethyl 5,5 ', 5'',5''- (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl ) &lt; / RTI &gt; tetrakis (furan-2-carboxylate). (Yield: 30.0%).

1H NMR (CDCl3): 7.39(d, 8H), 4,35(q, 8H), 3.28(s, 16H), 1,35(t, 12H) 1 H NMR (CDCl 3 ): 7.39 (d, 8H), 4,35 (q, 8H), 3.28

tetraethyl 5,5',5'',5'''-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl)tetrakis(furan-2-carboxylate) 12.6g과 NaOH 3.2g, MeOH 100ml, 정제수 75ml를 투입하고 55~60℃로 승온하여 12시간 교반하여 반응을 종결한다. 40℃로 냉각하고 진공 농축하여 용매를 제거하고 10% HCl 수용액으로 pH를 5~6로 맞추고 30분간 교반한다. MC 100ml를 투입하여 추출한다. 추출한 유기층은 MgSO4 처리하여 표제 화합물 7.9g을 수득하였다. (수율: 73.9%)tetraethyl 5,5 ', 5''- (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl) tetrakis (furan-2-carboxylate) , MeOH (100 ml) and purified water (75 ml). The mixture was heated to 55 to 60 ° C and stirred for 12 hours to terminate the reaction. Cool to 40 &lt; 0 &gt; C and concentrate in vacuo to remove the solvent, adjust the pH to 5-6 with 10% aqueous HCl and stir for 30 min. Add 100 ml of MC to extract. The organic layer was extracted to give the title compound, 7.9g MgSO 4 and treated. (Yield: 73.9%).

1H NMR (DMSO): 7.40(d, 8H), 3.29(s, 16H) 1 H NMR (DMSO): 7.40 (d, 8H), 3.29 (s, 16H)

<사이클람 유도체의 합성>&Lt; Synthesis of cyclam derivative >

실시예 9: 2,2',2'',2'''-(1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetrayl)tetraacetic acid (화학식 3e)의 제조Example 9: Preparation of 2,2 ', 2 ", 2' '- (1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetrayl) tetraacetic acid (Formula 3e)

Figure pat00039
Figure pat00039

Cyclam 10.0g과 acetonitrile 400.0ml를 투입 교반하고 K2CO3 34.5g과 Ethyl bromoacetate 36.7g을 투입하고 승온하여 40시간 환류교반하여 반응을 종결한다. 상온으로 냉각하여 여과하여 고체는 폐기하고 여액은 진공 농축한다. 농축액에 MC 200ml, 정제수 300ml 투입후 30분간 교반후 정치하여 층분리한다. 유기층은 MgSO4 처리하여 진공 농축 후 MC-MeOH로 컬럼정제하여 tetraethyl 2,2',2'',2'''-(1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetrayl)tetraacetate 15.4g을 수득하였다. (수율: 56.8%)Cyclam (10.0 g) and acetonitrile (400.0 ml) were added and stirred, 34.5 g of K 2 CO 3 and 36.7 g of ethyl bromoacetate were added, and the mixture was heated to reflux for 40 hours to complete the reaction. After cooling to room temperature, the solid is discarded by filtration and the filtrate is concentrated in vacuo. Add 200 ml of MC and 300 ml of purified water to the concentrate, stir for 30 minutes, and separate. The organic layer was dried over MgSO 4, concentrated in vacuo and column-purified with MC-MeOH to give tetraethyl 2,2 ', 2'',2''' - (1,4,8,11-tetraazacyclotetradecane- tetrayl) tetraacetate. (Yield: 56.8%)

1H NMR (CDCl3): 4.12(q, 8H), 3.36(s, 8H), 2,69~2.73(m, 16H), 1,60(m, 4H), 1.26(t, 12H) 1 H NMR (CDCl 3 ): 4.12 (q, 8H), 3.36 (s, 8H), 2.69-2.73 (m, 16H)

tetraethyl 2,2',2'',2'''-(1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetrayl)tetraacetate 15.4g과 NaOH 5.2g, MeOH 90ml, 정제수 60ml를 투입하고 55~60℃로 승온하여 12시간 교반하여 반응을 종결한다. 40℃로 냉각하고 진공 농축하여 용매를 제거하고 10% HCl 수용액으로 pH를 5~6로 맞추고 30분간 교반한다. MC 200ml를 투입하여 추출한다. 추출한 유기층은 MgSO4 처리하여 표제 화합물 9.3g을 수득하였다. (수율: 75.9%)15.4 g of tetraethyl 2,2 ', 2'',2''- (1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetrayl) tetraacetate, 5.2 g of NaOH, 90 ml of MeOH, The mixture was heated to 55 to 60 ° C and stirred for 12 hours to terminate the reaction. Cool to 40 &lt; 0 &gt; C and concentrate in vacuo to remove the solvent, adjust the pH to 5-6 with 10% aqueous HCl and stir for 30 min. 200 ml of MC is added to extract. The extracted organic layer was treated with MgSO 4 to obtain 9.3 g of the title compound. (Yield: 75.9%).

1H NMR (D2O): 3.51(s, 8H), 3.14(s, 8H), 3.07(t, 8H), 1.85(q, 4H) 1 H NMR (D 2 O): 3.51 (s, 8H), 3.14 (s, 8H)

실시예 10: 4,4',4'',4'''-(1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetrayl)tetrabenzoic acid (화학식 3f)의 제조Example 10: Preparation of 4,4 ', 4 ", 4"' - (1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetrayl) tetrabenzoic acid (Formula 3f)

Figure pat00040
Figure pat00040

Cyclam 10.0g, ethyl 4-bromobenzoate 50.3g, t-BuONa 24.0g과 toluene 400ml를 투입 교반한다. 35℃로 승온하여 50% (t-Bu)3P toluene solution 2.0g을 투입하고 30분간 교반하고 50℃로 승온한 후 Pd(dba)2 1.5g을 투입하고 승온하여 환류교반하여 반응을 종결한다. 상온으로 냉각하여 정제수 1000ml를 투입하고 30분간 교반 정치하여 층분리하여 수층은 폐기한다. 유기층은 MgSO4 처리하여 진공 농축 후 MC-MeOH 컬럼 정제하여 tetraethyl 4,4',4'',4'''-(1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetrayl)tetrabenzoate 12.3g을 수득 하였다. (수율: 31.0%)Cyclam (10.0 g), ethyl 4-bromobenzoate (50.3 g), t-BuONa (24.0 g) and toluene (400 ml). The temperature was raised to 35 ° C and 2.0 g of 50% (t-Bu) 3 P toluene solution was added. After stirring for 30 minutes, the temperature was raised to 50 ° C. and 1.5 g of Pd (dba) 2 was added. . After cooling to room temperature, 1000 ml of purified water is added, and the mixture is left to stand for 30 minutes to separate the layers, and the aqueous layer is discarded. The organic layer was dried over MgSO 4, concentrated in vacuo and purified by MC-MeOH column to obtain tetraethyl 4,4 ', 4'',4''' - (1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetrayl ) tetrabenzoate. &lt; / RTI &gt; (Yield: 31.0%).

1H NMR (CDCl3): 7.80(d, 8H), 6.94(d, 8H),4.13(q, 8H), 2,65~2.71(m, 16H), 1,65(m, 4H), 1.26(t, 12H) 1 H NMR (CDCl 3 ): 7.80 (d, 8H), 6.94 (d, 8H), 4.13 (q, 8H), 2.65-2.71 (t, 12H)

tetraethyl 4,4',4'',4'''-(1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetrayl)tetrabenzoate 12.3g과 NaOH 2.6g, MeOH 100ml, 정제수 70ml를 투입하고 55~60℃로 승온하여 12시간 교반하여 반응을 종결한다. 40℃로 냉각하고 진공 농축하여 용매를 제거하고 10% HCl 수용액으로 pH를 5~6로 맞추고 30분간 교반한다. MC 100ml를 투입하여 추출한다. 추출한 유기층은 MgSO4 처리하여 표제 화합물 8.6g을 수득하였다. (수율: 81.2%)tetrabenzoate tetrabenzoate, 2.6 g of NaOH, 100 ml of MeOH, and 70 ml of purified water were added to a solution of 4,4 ', 4'',4''- (1,4,8,11-tetraazacyclotetradecane-1,4,8,11- The mixture was heated to 55 to 60 ° C and stirred for 12 hours to terminate the reaction. Cool to 40 &lt; 0 &gt; C and concentrate in vacuo to remove the solvent, adjust the pH to 5-6 with 10% aqueous HCl and stir for 30 min. Add 100 ml of MC to extract. The extracted organic layer was treated with MgSO 4 to obtain 8.6 g of the title compound. (Yield: 81.2%).

1H NMR (DMSO): 7.83(d, 8H), 6.95(d, 8H), 2,63~2.73(m, 16H), 1,62(m, 4H) 1 H NMR (DMSO): 7.83 (d, 8H), 6.95 (d, 8H), 2.63-2.73

실시예 11: 5,5',5'',5'''-(1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetrayl)tetranicotinic acid (화학식 3g)의 제조Example 11: Preparation of 5,5 ', 5 ", 5"' - (1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetrayl) tetranicotinic acid (Formula 3g)

Figure pat00041
Figure pat00041

Cyclam 10.0g, ethyl 5-bromonicotinate 50.3g, t-BuONa 24.0g과 xylene 400ml를 투입 교반한다. 35℃로 승온하여 50% (t-Bu)3P toluene solution 2.0g을 투입하고 30분간 교반하고 50℃로 승온한 후 Pd(dba)2 1.5g을 투입하고 승온하여 환류교반하여 반응을 종결한다. 상온으로 냉각하여 정제수 1000ml를 투입하고 30분간 교반 정치하여 층분리하여 수층은 폐기한다. 유기층은 MgSO4 처리하여 진공 농축 후 MC-MeOH 컬럼 정제하여 tetraethyl 5,5',5'',5'''-(1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetrayl)tetranicotinate 11.1g을 수득 하였다. (수율: 27.8%)Cyclam (10.0 g), ethyl 5-bromonicotinate (50.3 g), t-BuONa (24.0 g) and xylene (400 ml). The temperature was raised to 35 ° C and 2.0 g of 50% (t-Bu) 3 P toluene solution was added. After stirring for 30 minutes, the temperature was raised to 50 ° C. and 1.5 g of Pd (dba) 2 was added. . After cooling to room temperature, 1000 ml of purified water is added, and the mixture is left to stand for 30 minutes to separate the layers, and the aqueous layer is discarded. The organic layer was dried over MgSO 4, concentrated in vacuo and purified by MC-MeOH column to obtain tetraethyl 5,5 ', 5'',5''' - (1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetrayl ) tetranicotinate. (Yield: 27.8%)

1H NMR (CDCl3): 8.91(d, 4H), 8.37(d, 4H), 7.85(d, 4H), 4.15(q, 8H), 2,67~2.64(m, 16H), 1,71(m, 4H), 1.24(t, 12H) 1 H NMR (CDCl 3 ): 8.91 (d, 4H), 8.37 (d, 4H), 7.85 (m, 4 H), 1.24 (t, 12 H)

tetraethyl 5,5',5'',5'''-(1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetrayl)tetranicotinate 11.1g과 NaOH 2.6g, MeOH 90ml, 정제수 70ml를 투입하고 55~60℃로 승온하여 12시간 교반하여 반응을 종결한다. 40℃로 냉각하고 진공 농축하여 용매를 제거하고 10% HCl 수용액으로 pH를 5~6로 맞추고 30분간 교반한다. MC 120ml를 투입하여 추출한다. 추출한 유기층은 MgSO4 처리하여 표제 화합물 7.4g을 수득하였다. (수율: 77.6%)tetraethyl 5,5 ', 5'',5''- (1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetrayl) tetranicotinate, 2.6 g of NaOH, 90 ml of MeOH, The mixture was heated to 55 to 60 ° C and stirred for 12 hours to terminate the reaction. Cool to 40 &lt; 0 &gt; C and concentrate in vacuo to remove the solvent, adjust the pH to 5-6 with 10% aqueous HCl and stir for 30 min. Add 120 ml of MC to extract. The organic layer was extracted to give the title compound, 7.4g MgSO 4 and treated. (Yield: 77.6%).

1H NMR (DMSO): 8.93(d, 4H), 8.38(d, 4H), 7.85(d, 4H), 2,67~2.66(m, 16H), 1,72(m, 4H) 1 H NMR (DMSO): 8.93 (d, 4H), 8.38 (d, 4H), 7.85 (d, 4H), 2,67 ~ 2.66 (m, 16H), 1,72 (m, 4H)

실시예 12: 5,5',5'',5'''-(1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetrayl)tetrakis(furan-2-carboxylic acid) (화학식 3h)의 제조Example 12: 5,5 ', 5 "' - (1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetrayl) tetrakis (furan-2-carboxylic acid) 3h)

Figure pat00042
Figure pat00042

Cyclam 10.0g, ethyl 5-bromofuran-2-carboxylate 48.1g, t-BuONa 24.0g과 toluene 400ml를 투입 교반한다. 35℃로 승온하여 50% (t-Bu)3P toluene solution 2.0g을 투입하고 30분간 교반하고 50℃로 승온한 후 Pd(dba)2 1.5g을 투입하고 승온하여 환류교반하여 반응을 종결한다. 상온으로 냉각하여 정제수 1000ml를 투입하고 30분간 교반 정치하여 층분리하여 수층은 폐기한다. 유기층은 MgSO4 처리하여 진공 농축 후 MC-MeOH 컬럼 정제하여 tetraethyl 5,5',5'',5'''-(1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetrayl)tetrakis(furan-2-carboxylate) 14.1g을 수득 하였다. (수율: 37.5%)Cyclam, 48.1 g of ethyl 5-bromofuran-2-carboxylate, 24.0 g of t-BuONa and 400 ml of toluene are stirred. The temperature was raised to 35 ° C and 2.0 g of 50% (t-Bu) 3 P toluene solution was added. After stirring for 30 minutes, the temperature was raised to 50 ° C. and 1.5 g of Pd (dba) 2 was added. . After cooling to room temperature, 1000 ml of purified water is added, and the mixture is left to stand for 30 minutes to separate the layers, and the aqueous layer is discarded. The organic layer was dried over MgSO 4, concentrated in vacuo and purified by MC-MeOH column to obtain tetraethyl 5,5 ', 5'',5''' - (1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetrayl ) tetrakis (furan-2-carboxylate). (Yield: 37.5%).

1H NMR (CDCl3): 7.40(d, 8H), 4.23(q, 8H), 2,65~2.71(m, 16H), 1,66(m, 4H), 1.29(t, 12H) 1 H NMR (CDCl 3 ): 7.40 (d, 8H), 4.23 (q, 8H), 2.65-2.71 (m, 16H)

tetraethyl 5,5',5'',5'''-(1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetrayl)tetrakis(furan-2-carboxylate) 14.1g과 NaOH 3.5g, MeOH 110ml, 정제수 85ml를 투입하고 55~60℃로 승온하여 12시간 교반하여 반응을 종결한다. 40℃로 냉각하고 진공 농축하여 용매를 제거하고 10% HCl 수용액으로 pH를 5~6로 맞추고 30분간 교반한다. MC 120ml를 투입하여 추출한다. 추출한 유기층은 MgSO4 처리하여 표제 화합물 9.4g을 수득하였다.(수율: 78.1%)tetraethyl 5,5 ', 5''- (1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetrayl) tetrakis (furan-2-carboxylate) , MeOH (110 ml) and purified water (85 ml). The mixture was heated to 55 to 60 ° C and stirred for 12 hours to terminate the reaction. Cool to 40 &lt; 0 &gt; C and concentrate in vacuo to remove the solvent, adjust the pH to 5-6 with 10% aqueous HCl and stir for 30 min. Add 120 ml of MC to extract. The extracted organic layer was treated with MgSO 4 to obtain 9.4 g of the title compound (yield: 78.1%).

1H NMR (DMSO): 7.41(d, 8H), 2,69~2.72(m, 16H), 1,68(m, 4H) 1 H NMR (DMSO): 7.41 (d, 8H), 2.69-2.72 (m, 16H), 1.68 (m, 4H)

실시예Example 13 내지 27: 공기 필터의 제조 13 to 27: Manufacture of air filter

트리엔틴, 사이클렌, 사이클람 및 상기 실시예 1 내지 12에서 제조된 트리엔틴 유도체, 사이클렌 유도체, 사이클람 유도체를 1% 수용액으로 제조한 다음, 시중에서 판매되는 공기 필터용 5T 부직포(PET 소재)를 구입하여 10 cm * 10 cm 로 절단한 후, 상기 수용액에 30초간 스프레이 분사시켜 충분히 적신 다음, 3시간 건조시켜 본 발명에 따른 유효성분이 함유된 필터를 제조하였다.Triene, cyclane, cyclam, and the trientine derivatives, cyclic derivatives and cyclam derivatives prepared in the above Examples 1 to 12 were prepared in a 1% aqueous solution and then commercially available 5T nonwoven fabric for air filters PET material) was cut into 10 cm * 10 cm, sprayed for 30 seconds in the aqueous solution, sufficiently wetted, and dried for 3 hours to prepare a filter containing the active ingredient according to the present invention.

공기 필터의 각 유효 성분들을 하기 표 1에 나타내었다.The effective components of the air filter are shown in Table 1 below.

공기 필터Air filter 유효성분Active ingredient 실시예 13Example 13 트리엔틴Trientine 실시예 14Example 14 실시예 1Example 1 실시예 15Example 15 실시예 2Example 2 실시예 16Example 16 실시예 3Example 3 실시예 17Example 17 실시예 4Example 4 실시예 18Example 18 사이클렌Cyclen 실시예 19Example 19 실시예 5Example 5 실시예 20Example 20 실시예 6Example 6 실시예 21Example 21 실시예 7Example 7 실시예 22Example 22 실시예 8Example 8 실시예 23Example 23 사이클람Cyclam 실시예 24Example 24 실시예 9Example 9 실시예 25Example 25 실시예 10Example 10 실시예 26Example 26 실시예 11Example 11 실시예 27Example 27 실시예 12Example 12 비교예 1Comparative Example 1 --

실험예Experimental Example 1: 공기 필터의 중금속  1: Heavy metal of air filter 제거능Removability 시험 exam

상기 제조된 필터들은 폐쇄된 공간에 나란히 세워두고 외부에서 포집된 다량의 미세먼지를 투입한 후, 필터들에 미세먼지가 부착되도록 내부에 설치된 팬들을 1일 동안 가동시킨 다음, 오염된 필터들을 증류수(1L)에 넣어 혼합한 후, 총중금속 검사 키트(WAK-MeTM, 일본 Kyoritsu Chemical-Check Lab.)를 이용하여 미세먼지 수용액의 총중금속량(Cu, Zn, Mn, Ni,Cd)을 측정하였다.The prepared filters were placed in a closed space and a large amount of fine dust collected from the outside was put in. Then, the fans installed inside the filters were moved for one day so that fine dusts adhered to the filters, (Cu, Zn, Mn, Ni, Cd) of the fine dust water solution was measured using a total heavy metal test kit (WAK-Me , Kyoritsu Chemical-Check Lab. Respectively.

총중금속량의 측정은 수용액의 발색을 표준 색상과 비교하여 그 결과를 표 2에 도시하였다.The total amount of heavy metals was measured by comparing the color of the aqueous solution with the standard color, and the results are shown in Table 2.

(황색) 0 ppm 0.2 ppm 0.5 ppm 1.0 ppm 2.0 ppm ≤5 ppm (적색)(Yellow) 0 ppm 0.2 ppm 0.5 ppm 1.0 ppm 2.0 ppm? 5 ppm (red)

필터filter 유효성분Active ingredient 총중금속량(Cu, Zn, Mn, Ni, Cd) (ppm)Total amount of heavy metals (Cu, Zn, Mn, Ni, Cd) (ppm) 실시예 13Example 13 트리엔틴Trientine ≤5 (적색)≤5 (red) 실시예 14Example 14 실시예 1Example 1 ≤5≤ 5 실시예 15Example 15 실시예 2Example 2 ≤5≤ 5 실시예 16Example 16 실시예 3Example 3 ≤5≤ 5 실시예 17Example 17 실시예 4Example 4 ≤5≤ 5 실시예 18Example 18 사이클렌Cyclen ≤5≤ 5 실시예 19Example 19 실시예 5Example 5 ≤5≤ 5 실시예 20Example 20 실시예 6Example 6 ≤5≤ 5 실시예 21Example 21 실시예 7Example 7 ≤5≤ 5 실시예 22Example 22 실시예 8Example 8 ≤5≤ 5 실시예 23Example 23 사이클람Cyclam ≤5≤ 5 실시예 24Example 24 실시예 9Example 9 ≤5≤ 5 실시예 25Example 25 실시예 10Example 10 ≤5≤ 5 실시예 26Example 26 실시예 11Example 11 ≤5≤ 5 실시예 27Example 27 실시예 12Example 12 ≤5≤ 5 비교예 1Comparative Example 1 -- 2.02.0

상기 표 2에 보이는 바와 같이 본 발명의 유효성분을 함유하지 않은 비교예 1의 필터에는 총중금속량은 2.0 ppm 이었으나, 본 발명에 따른 필터에 함유된 총중금속량은 모두 5 ppm 이상(≤5)으로 본 발명에 따른 필터들의 유해 중금속 흡착능이 현저한 것을 확인할 수 있다.As shown in Table 2, the total amount of heavy metals contained in the filter according to the present invention was 5 ppm or more (≤5) in the filter of Comparative Example 1 which did not contain the active ingredient of the present invention, It can be seen that the filters according to the present invention have a remarkable ability to adsorb harmful heavy metals.

실험예Experimental Example 2: 유효성분의 피부 자극도 시험 2: Skin irritation test of active ingredient

20-30대 남녀 각각 10명, 총 20명을 대상으로 CTFA(The Cosmetic, Toiletry & Fragrance Association. Inc. Washington, D.C., 20036, 1991) 가이드라인에 따라 첩포의 방법으로 인체피부 1차 자극시험을 실시하였다.A total of 20 subjects, 20 men and 10 women in their 20s and 30s, underwent a primary skin irritation test using the patch method according to the CTFA guidelines (The Cosmetic, Toiletry & Fragrance Association, Inc., Washington, DC, Respectively.

먼저 8mm 직경, 10 패널 핀 챔버(Finn Chamber)에 쳄버용 필터페이퍼 디스크를 안치시키고 상기 실험예 1에 따른 외피용 조성물을 각각 20㎕씩 적하시키고, 10분간 자연 건조시킨 후, 등 부위에 Scanpor tape로 고정시켰다.First, a filter paper disk for a chamber was placed in a 8-mm diameter, 10-panel pin chamber, 20 ㎕ each of the composition for a skin according to Experimental Example 1 was dropped, naturally dried for 10 minutes, Respectively.

24시간 경과 후 핀 챔버를 제거하고 육안으로 피부 변화를 관찰하여 하기 수학식 2에 따라 피부 자극도 및 판정 등급을 계산하여 하기 표 3에 그 결과를 나타내었다.After 24 hours, the pin chamber was removed, and skin changes were observed with the naked eye. The skin irritation degree and the judgment grade were calculated according to the following formula (2), and the results are shown in the following Table 3.

Figure pat00043
Figure pat00043

[피부 자극 판정 기준][Criteria for skin irritation]

(-): 홍반이나 특히 현상 없음; (±주위보다 약간 붉어짐; (+): 주위보다 현저히 붉어짐; (++): 주위보다 심하게 붉어지고 부풀어 오름. (-): No erythema or particularly no symptoms; (+ Slightly redder than ±; (+): markedly redder than surrounding; (++): more reddened and swollen than surrounding.

[피부 자극 판정 등급][Skin irritation judgment level]

자극도 0~0.1: 등급 Ⅰ(무자극 범위); 0.11~0.3: 등급 Ⅱ(경자극 범위); 0.31~0.5: 등급 Ⅲ(중자극 범위); 0.51이상: 등급 Ⅳ(강자극 범위)Stimulation 0 to 0.1: Grade I (unstimulated range); 0.11-0.3: grade II (light stimulus range); 0.31-0.5: grade III (moderate stimulus range); 0.51 or higher: Grade IV (range of strong stimulus)

시료sample 판정 결과(인원)Judgment result (person) 자극도Irritation degree 등급Rating 유효성분Active ingredient 함량(중량%)Content (% by weight) (-)(-) (+)(+) (++)(++) 트리엔틴Trientine 0.1%0.1% 2020 00 00 00 00 II 0.5%0.5% 1919 1One 00 00 0.050.05 II 1.0%1.0% 1717 33 00 00 0.150.15 IIII 실시예 1Example 1 0.1%0.1% 2020 00 00 00 00 II 0.5%0.5% 1919 1One 00 00 0.050.05 II 1.0%1.0% 1616 44 00 00 0.200.20 IIII 실시예 2Example 2 0.1%0.1% 2020 00 00 00 00 II 0.5%0.5% 2020 00 00 00 00 II 1.0%1.0% 1919 1One 00 00 0.050.05 II 실시예 3Example 3 0.1%0.1% 2020 00 00 00 00 II 0.5%0.5% 2020 00 00 00 00 II 1.0%1.0% 1919 1One 00 00 0.050.05 II 실시예 4Example 4 0.1%0.1% 2020 00 00 00 00 II 0.5%0.5% 2020 00 00 00 00 II 1.0%1.0% 1919 1One 00 00 0.050.05 II 사이클렌Cyclen 0.1%0.1% 2020 00 00 00 00 II 0.5%0.5% 2020 00 00 00 00 II 1.0%1.0% 1818 1One 1One 00 0.150.15 IIII 실시예 5Example 5 0.1%0.1% 2020 00 00 00 00 II 0.5%0.5% 2020 00 00 00 00 II 1.0%1.0% 1919 1One 00 00 0.050.05 II 실시예 6Example 6 0.1%0.1% 2020 00 00 00 00 II 0.5%0.5% 2020 00 00 00 00 II 1.0%1.0% 1919 1One 00 00 0.050.05 II 실시예 7Example 7 0.1%0.1% 2020 00 00 00 00 II 0.5%0.5% 2020 00 00 00 00 II 1.0%1.0% 2020 00 00 00 00 II 실시예 8Example 8 0.1%0.1% 2020 00 00 00 00 II 0.5%0.5% 2020 00 00 00 00 II 1.0%1.0% 1818 22 00 00 0.100.10 II 사이클람Cyclam 0.1%0.1% 2020 00 00 00 00 II 0.5%0.5% 1919 1One 00 00 0.050.05 II 1.0%1.0% 1717 33 00 00 0.150.15 IIII 실시예 9Example 9 0.1%0.1% 2020 00 00 00 00 II 0.5%0.5% 2020 00 00 00 00 II 1.0%1.0% 1818 22 00 00 0.100.10 II 실시예 10Example 10 0.1%0.1% 2020 00 00 00 00 II 0.5%0.5% 2020 00 00 00 00 II 1.0%1.0% 1919 1One 00 00 0.050.05 II 실시예 11Example 11 0.1%0.1% 2020 00 00 00 00 II 0.5%0.5% 2020 00 00 00 00 II 1.0%1.0% 1818 22 00 00 0.100.10 II 실시예 12Example 12 0.1%0.1% 2020 00 00 00 00 II 0.5%0.5% 2020 00 00 00 00 II 1.0%1.0% 1919 1One 00 00 0.050.05 II 비교예 1
(EDTA)
Comparative Example 1
(EDTA)
0.1%0.1% 2020 22 00 00 0.100.10 II
0.5%0.5% 1717 22 1One 00 0.200.20 IIII 1.0%1.0% 1515 33 22 00 0.350.35 IIIIII

상기 표 3에 나타나는 바와 같이, 본 발명의 실시예에 따른 중금속 킬레이트제 화합물은 인체 피부 자극 실험에서 0.5 중량% 농도 범위까지는 모두 무자극 범위인 등급 Ⅰ을 보였으며, 1.0 중량% 농도 범위에서는 트리엔틴, 사이클렌, 사이클람은 등급 Ⅱ(경자극 범위)를 보인 반면, 이들의 방향족, 복소환 유도체에서는 모두 등급 I을 보여 피부 자극 감소가 향상됨을 알 수 있다. 반면, 비교예 1의 EDTA는 1.0 중량% 농도에서 등급 Ⅲ(중자극 범위)으로 판정되어 본 발명의 화합물에 비해 피부 자극도가 높은 것을 알 수 있다. 따라서 본 발명에 따른 필터는 인체에 무해하여 담배 필터나 공기 마스크 등에 이용될 수 있음을 알 수 있다.As shown in Table 3, the heavy metal chelating compound according to the present invention showed grade I in a non-stimulated range up to a concentration of 0.5 wt% in a human skin irritation test. In the concentration range of 1.0 wt% Tin, cyclane, and cyclam showed grade II (light stimulus range) while all of these aromatics and heterocyclic derivatives showed grade I, indicating reduced skin irritation. On the other hand, the EDTA of Comparative Example 1 was judged to be grade III (moderate irritation range) at a concentration of 1.0 wt%, indicating that the skin irritancy is higher than that of the compound of the present invention. Therefore, it can be seen that the filter according to the present invention is harmless to the human body and can be used for a cigarette filter, an air mask or the like.

실시예Example 28 내지 42: 담배 필터의 제조 28 to 42: Preparation of a tobacco filter

트리엔틴, 사이클렌, 사이클람 및 상기 실시예 1 내지 12에서 제조된 트리엔틴 유도체, 사이클렌 유도체, 사이클람 유도체를 각각 0.5%, 1.0%, 2.0% 수용액으로 제조한 후, 시중에서 판매되는 담배를 구입하여 담배 필터의 아랫 1/4부분을 상기 수용액에 4초간 함침시켜 본 발명의 유효성분이 필터에 적절히 스며들게 한 다음, 1시간 건조시켜 본 발명의 유효성분을 함유하는 담배 필터를 제조하였다.Trienetine, cyclane, cyclam and the trientine derivatives, cyclic derivatives and cyclam derivatives prepared in Examples 1 to 12 were prepared in aqueous solutions of 0.5%, 1.0% and 2.0%, respectively, And the lower 1/4 portion of the cigarette filter was immersed in the aqueous solution for 4 seconds to allow the active ingredient of the present invention to be appropriately impregnated into the filter and then dried for 1 hour to prepare a cigarette filter containing the active ingredient of the present invention .

담배 필터의 유효성분을 하기 표 4에 나타내었다.The active ingredients of the tobacco filter are shown in Table 4 below.

필터filter 유효성분Active ingredient 실시예 28Example 28 트리엔틴Trientine 실시예 29Example 29 실시예 1Example 1 실시예 30Example 30 실시예 2Example 2 실시예 31Example 31 실시예 3Example 3 실시예 32Example 32 실시예 4Example 4 실시예 33Example 33 사이클렌Cyclen 실시예 34Example 34 실시예 5Example 5 실시예 35Example 35 실시예 6Example 6 실시예 36Example 36 실시예 7Example 7 실시예 37Example 37 실시예 8Example 8 실시예 38Example 38 사이클람Cyclam 실시예 39Example 39 실시예 9Example 9 실시예 40Example 40 실시예 10Example 10 실시예 41Example 41 실시예 11Example 11 실시예 42Example 42 실시예 12Example 12 비교예 2Comparative Example 2 --

실험예Experimental Example 3: 담배 필터의 중금속  3: Heavy metals of tobacco filter 제거능Removability

상기 실시예 2에서 제조된 유효성분을 함유하는 필터 담배들을 동일 유효성분 별 4개피을 1개조 샘플로 준비하고, 실제 흡연과 유사한 조건으로 설정된 흡입장치에 위치 고정한 후 불을 붙인후 흡입장치를 작동시켜 흡연을 실시하였다.Four cigarettes of the same effective ingredient were prepared as one sample of filter cigarettes containing the active ingredient prepared in Example 2, fixed to a suction device set in a similar condition to actual smoking, then fired, and then the suction device was operated Smoking was performed.

상기 흡연된 담배 필터들을 수거하여 각 샘플(4개피 1개조) 각각 메탄올 100 ml에 넣어 60분간 초음파 진탕하여 추출하고, 상온에서 식힌 다음 메탄올을 넣어 100 ml로 한 다음, 필터를 빼낸 시료들을 30 ml 정도로 농축하여 검액을 준비하였다.The smoked tobacco filters were collected and placed in 100 ml of methanol for each sample (4 quadrants). After cooling for 60 minutes with ultrasonic shaking, the mixture was cooled to room temperature and methanol was added to make 100 ml. To prepare a sample solution.

상기 준비된 검액을 유도결합플라즈마 질량분석기(ICP-MS, Inductively Coupled Plasma Mass Spectrometer)(XseriesTM 2, Thermo Fisher Scientific사, UK)를 이용하여 해당 중금속 성분을 분석하였다.The prepared sample solution was analyzed for heavy metal components using an inductively coupled plasma mass spectrometer (ICP-MS, Xseries 2, Thermo Fisher Scientific, UK).

ICP-MS에서 비소(As)의 측정질량(m/z)는 75, 카드뮴(Cd)은 114, 니켈(Ni) 60 위치의 수치를 측정하고, 하기 수학식 2와 같이 대조구 대비 중금속 흡착율을 계산하여 표 1에 나타내었다.The measured mass (m / z) of arsenic (As) in ICP-MS was 75, the values of cadmium (Cd) were 114 and nickel (Ni) 60 were measured and the heavy metal adsorption rate Are shown in Table 1.

Figure pat00044
Figure pat00044

시료sample 비소(As)Arsenic (As) 카드뮴(Cd)Cadmium (Cd) 니켈(Ni)Nickel (Ni) 유효성분Active ingredient 함량content 흡착량
(ppm)
Adsorption amount
(ppm)
흡착율
(%)
Adsorption rate
(%)
흡착량
(ppm)
Adsorption amount
(ppm)
흡착율
(%)
Adsorption rate
(%)
흡착량
(ppm)
Adsorption amount
(ppm)
흡착율
(%)
Adsorption rate
(%)
트리엔틴Trientine 0.5%0.5% 4646 200%200% 7979 176%176% 102102 155%155% 1.0%1.0% 5353 230%230% 8484 187%187% 125125 189%189% 2.0%2.0% 6262 270%270% 9696 213%213% 131131 198%198% 실시예 1Example 1 0.5%0.5% 4343 187%187% 7777 171%171% 8989 135%135% 1.0%1.0% 4848 209%209% 7979 176%176% 101101 153%153% 2.0%2.0% 6363 274%274% 8484 187%187% 122122 185%185% 실시예 2Example 2 0.5%0.5% 4444 191%191% 7575 167%167% 9494 142%142% 1.0%1.0% 4848 209%209% 8484 187%187% 9898 148%148% 2.0%2.0% 5858 252%252% 9393 207%207% 103103 156%156% 실시예 3Example 3 0.5%0.5% 4848 209%209% 7575 167%167% 8989 135%135% .0%.0% 5353 230%230% 8181 180%180% 102102 155%155% .0%.0% 6363 274%274% 8686 191%191% 126126 191%191% 실시예 4Example 4 0.5%0.5% 4747 204%204% 6767 149%149% 9191 138%138% 1.0%1.0% 5656 243%243% 7575 167%167% 9898 148%148% 2.0%2.0% 6161 265%265% 8080 178%178% 104104 158%158% 사이클렌Cyclen 0.5%0.5% 3939 170%170% 6565 144%144% 8989 135%135% 1.0%1.0% 4343 187%187% 7878 173%173% 9393 141%141% 2.0%2.0% 5656 243%243% 8282 182%182% 9898 148%148% 실시예 5Example 5 0.5%0.5% 4141 178%178% 5959 131%131% 8383 126%126% 1.0%1.0% 4646 200%200% 6666 147%147% 8888 133%133% 2.0%2.0% 5151 222%222% 7070 156%156% 8989 135%135% 실시예 6Example 6 0.5%0.5% 4040 174%174% 6161 136%136% 7979 120%120% 1.0%1.0% 4141 178%178% 6868 151%151% 8383 126%126% 2.0%2.0% 4646 200%200% 7373 162%162% 8787 132%132% 실시예 7Example 7 0.5%0.5% 3939 170%170% 6464 142%142% 9292 139%139% 1.0%1.0% 4646 200%200% 7171 158%158% 9797 147%147% 2.0%2.0% 5555 239%239% 7878 173%173% 102102 155%155% 실시예 8Example 8 0.5%0.5% 3737 161%161% 5858 129%129% 8686 130%130% 1.0%1.0% 4848 209%209% 6161 136%136% 9191 138%138% 2.0%2.0% 4949 213%213% 7070 156%156% 9999 150%150% 사이클람Cyclam 0.5%0.5% 3737 161%161% 6060 133%133% 7979 120%120% 1.0%1.0% 4141 178%178% 7171 158%158% 8686 130%130% 2.0%2.0% 5656 243%243% 7878 173%173% 8989 135%135% 실시예 9Example 9 0.5%0.5% 4141 178%178% 6161 136%136% 7676 115%115% 1.0%1.0% 4646 200%200% 6363 140%140% 8585 129%129% 2.0%2.0% 4545 196%196% 7070 156%156% 9696 145%145% 실시예 10Example 10 0.5%0.5% 3636 157%157% 5858 129%129% 8181 123%123% 1.0%1.0% 3939 170%170% 6363 140%140% 8989 135%135% 2.0%2.0% 5151 222%222% 7171 158%158% 9494 142%142% 실시예 11Example 11 0.5%0.5% 3737 161%161% 5959 131%131% 7979 120%120% 1.0%1.0% 4545 196%196% 6363 140%140% 9090 136%136% 2.0%2.0% 5151 222%222% 7070 156%156% 8989 135%135% 실시예 12Example 12 0.5%0.5% 3434 148%148% 5858 129%129% 7777 117%117% 1.0%1.0% 3939 170%170% 6767 149%149% 8585 129%129% 2.0%2.0% 4343 187%187% 7272 160%160% 8989 135%135% 대조구 1Control 1 -- 2323 4545 6666

상기 표 5에 도시된 바와 같이 본 발명의 실시예에 따른 중금속 킬레이트제 화합물을 함유하는 담배 필터의 비소(Pb) 흡착율은 대조구와 대비할 때, 약 148~274%, 카드뮴(Cd) 흡착율은 129~213%, 니켈(Ni) 흡착율은 117~191%로, 유효성분의 함량이 증가할 수록 중금속 흡착율이 유의적으로 증가하는 것을 확인할 수 있다.As shown in Table 5, the adsorption rate of arsenic (Pb) of the tobacco filter containing the heavy metal chelating compound according to the present invention was about 148-274% and the adsorption rate of cadmium (Cd) 213% and nickel (Ni) adsorption rate was 117 ~ 191%. As the content of active ingredient increased, the adsorption rate of heavy metal was significantly increased.

이는 본 발명에 따른 유효성분을 함유하는 담배 필터가 유효성분 비함유 담배 필터에 비해 현저히 우수한 중금속 제거능을 가짐을 의미한다.This means that the tobacco filter containing the active ingredient according to the present invention has a remarkably excellent heavy metal removal ability as compared with the active ingredient-free tobacco filter.

실험예Experimental Example 4: 포름알데히드  4: formaldehyde 제거능Removability 시험 exam

35.0% 포름알데히드 용액에 정제수를 넣고 2.0% 포름알데히드 희석액을 제조하였다. 상기 희석액에 3 mol 당량에 해당하는 본 발명의 트리엔틴, 사이클렌, 사이클람과 이들의 유도체 화합물을 각각 투입하고 상온에서 교반하면서 포름알데히드 변화량을 가스 크로마토그래피(GC) 분석을 실시하여 관찰하였다.Purified water was added to a 35.0% formaldehyde solution to prepare a 2.0% formaldehyde diluted solution. To the diluted solution, trientine, cyclane, cyclam, and derivative compounds of the present invention corresponding to 3 molar equivalents were added, and the amount of formaldehyde change was analyzed by GC analysis while stirring at room temperature .

포름알데히드의 함량은 하기 분석조건에서 실시되었으며, 초기, 30분, 180분 경과 후 포름알데히드의 함량을 표 6에 도시하였다.The content of formaldehyde was measured under the following analysis conditions, and the contents of formaldehyde after the initial, 30 minutes, and 180 minutes were shown in Table 6.

<GC 분석조건><GC analysis conditions>

- 검출기: 불꽃이온화검출기 - Detector: Flame ionization detector

- 칼럼: ZB-1 (0.32 mm × 30 m, 3.00 μm) 또는 이와 유사한 칼럼. Column: ZB-1 (0.32 mm x 30 m, 3.00 m) or a similar column.

- 헤드스페이스조건: 평형온도 60 ℃, 평형시간 10 분, 이송라인온도 : 65℃ - Headspace conditions: equilibrium temperature 60 캜, equilibration time 10 min, transfer line temperature 65 캜

- 칼럼온도: 처음 5 분간 50 ℃로 유지하고, 그 다음 매 분 30 ℃씩 200 ℃까지 온도를 올리고 200 ℃에서 10 분간 유지. - Column temperature: keep at 50 ° C for the first 5 minutes, then increase the temperature to 200 ° C by 30 ° C per minute and maintain at 200 ° C for 10 minutes.

- 검체도입부온도: 140 ℃ 부근의 일정 온도. - Specimen inlet temperature: constant temperature around 140 ℃.

- 검출기온도: 250 ℃ 부근의 일정 온도. - Detector temperature: constant temperature around 250 ℃.

- 운반기체: 질소 - Carrier gas: nitrogen

- 분할 비: 약 1:20 - Split ratio: about 1:20

- 유 량: 2.5 mL/분 - Flow rate: 2.5 mL / min

- 주입량: 검액 5uL를 마이크로 실린지로 바이알에 주입 밀전후 헤드스페이스조건에 따라 유지하고 증기상 1 mL를 칼럼에 주입. - Injection amount: 5 uL of the test solution is injected into the vial with microcirrins. Before and after the milling, keep it according to the head space conditions and inject 1 mL of the vapor phase into the column.

- 분석시간 : 20 분 - Analysis time: 20 minutes

유효성분Active ingredient 면적(mAU*min)Area (mAU * min) InitialInitial 30분30 minutes 180분180 minutes 트리엔틴Trientine 0.3050.305 0.1680.168 00 실시예 1Example 1 0.3050.305 0.1700.170 00 실시예 2Example 2 0.3050.305 0.1680.168 00 실시예 3Example 3 0.3050.305 0.1710.171 00 실시예 4Example 4 0.3050.305 0.1730.173 00 사이클렌Cyclen 0.3050.305 0.1810.181 00 실시예 5Example 5 0.3050.305 0.1790.179 00 실시예 6Example 6 0.3050.305 0.1830.183 00 실시예 7Example 7 0.3050.305 0.1810.181 00 실시예 8Example 8 0.3050.305 0.1680.168 00 사이클람Cyclam 0.3050.305 0.1720.172 00 실시예 9Example 9 0.3050.305 0.1820.182 00 실시예 10Example 10 0.3050.305 0.1710.171 00 실시예 11Example 11 0.3050.305 0.1740.174 00 실시예 12Example 12 0.3050.305 0.1700.170 00

상기 표 6에 보이는 바와 같이 GC 분석 결과, 본 발명의 화합물 투입 30분 만에 포름알데히드는 초기 대비 40~45% 정도 줄었으며, 180분 후에는 검출되지 않아 완전 사라짐을 확인하였다. 이는 본 발명의 유효성분이 포름알데히드와 효과적으로 흡착함을 의미하는 것으로, 본 발명에 따른 가구 세정용 조성물은 새집증후군의 원인 물질인 포름알데히드 제거에 유용하게 이용될 수 있음을 알 수 있다.As shown in Table 6, GC analysis showed that the formaldehyde was reduced by 40 to 45% in 30 minutes after the addition of the compound of the present invention, but was completely undetected after 180 minutes. This means that the active ingredient of the present invention adsorbs effectively with formaldehyde, and that the composition for cleaning households according to the present invention can be effectively used for removing formaldehyde, which is a causative substance of shedding syndrome.

Claims (13)

하기 화학식 1로 표시되는 트리엔틴 또는 트리엔틴 유도체, 하기 화학식 2로 표시되는 사이클렌 또는 사이클렌 유도체, 하기 화학식 3으로 표시되는 사이클람 또는 사이클람 유도체 중에서 선택된 1종 이상을 유효성분으로 하는, 중금속 및 포름알데히드 제거능을 가지는 필터.
[화학식 1]
Figure pat00045

[화학식 2]
Figure pat00046

[화학식 3]
Figure pat00047

(상기 식들에서, R1, R2, R3, R4, R5 및 R6은 각각 독립적으로 수소, -R7-COOH 또는 이들의 염이고, R7은 C1~C5의 지방족, 치환되거나 치환되지 않은 방향족 고리, 또는 복소환 6원자 또는 5원자 고리이다.)
A triene or triene derivative represented by the following general formula (1), a cyclane or a cyclene derivative represented by the following general formula (2), a cyclam or a cyclam derivative represented by the general formula (3) , Heavy metals and formaldehyde.
[Chemical Formula 1]
Figure pat00045

(2)
Figure pat00046

(3)
Figure pat00047

Wherein R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are each independently hydrogen, -R 7 -COOH or a salt thereof, R 7 is a C 1 to C 5 aliphatic, A substituted or unsubstituted aromatic ring, or a heterocyclic 6-atom or 5-membered ring.
제1항에 있어서,
상기 유효성분은 하기 화학식 1a의 트리엔틴, 화학식 2a의 사이클렌, 화학식 3a의 사이클람 또는 이들의 염 중에서 선택되는 것인, 중금속 및 포름알데히드 제거능을 가지는 필터.
[화학식 1a]
Figure pat00048

[화학식 2a]
Figure pat00049

[화학식 3a]
Figure pat00050

The method according to claim 1,
Wherein the active ingredient is selected from the group consisting of trienes of the following general formula (1a), cyclans of the general formula (2a), cyclam of the general formula (3a) or salts thereof.
[Formula 1a]
Figure pat00048

(2a)
Figure pat00049

[Chemical Formula 3]
Figure pat00050

제1항에 있어서,
상기 트리엔틴 유도체는 하기 화학식 1b 내지 1d로 표시되는 화합물 또는 이들의 염 중에서 선택되는 것인, 중금속 및 포름알데히드 제거능을 가지는 필터.
[화학식 1b]
Figure pat00051

[화학식 1c]
Figure pat00052

[화학식 1d]
Figure pat00053

(상기 식들에서, R8, R9는 각각 독립적으로 수소 또는 C1~C4의 알킬기이고, X는 산소(O), 황(S) 또는 질소(N)이다.)
The method according to claim 1,
Wherein the trienetine derivative is selected from the group consisting of compounds represented by the following formulas (1b) to (1d) or salts thereof: a heavy metal and a formaldehyde-removing filter.
[Chemical Formula 1b]
Figure pat00051

[Chemical Formula 1c]
Figure pat00052

&Lt; RTI ID = 0.0 &
Figure pat00053

(Wherein R 8 and R 9 are each independently hydrogen or a C 1 -C 4 alkyl group and X is oxygen (O), sulfur (S) or nitrogen (N).)
제1항에 있어서,
상기 사이클렌 유도체는 하기 화학식 2b 내지 2d로 표시되는 화합물 또는 이들의 염 중에서 선택되는 것인, 중금속 및 포름알데히드 제거능을 가지는 필터.
[화학식 2b]
Figure pat00054

[화학식 2c]
Figure pat00055

[화학식 2d]
Figure pat00056

(상기 식들에서, R8, R9는 각각 독립적으로 수소 또는 C1~C4의 알킬기이고, X는 산소(O), 황(S) 또는 질소(N)이다.)
The method according to claim 1,
Wherein the cyclic derivative is selected from the group consisting of compounds represented by the following formulas (2b) to (2d) or salts thereof.
(2b)
Figure pat00054

[Chemical Formula 2c]
Figure pat00055

(2d)
Figure pat00056

(Wherein R 8 and R 9 are each independently hydrogen or a C 1 -C 4 alkyl group and X is oxygen (O), sulfur (S) or nitrogen (N).)
제1항에 있어서,
상기 사이클람 유도체는 하기 화학식 3b 내지 3d로 표시되는 화합물 또는 이들의 염 중에서 선택되는 것인, 중금속 및 포름알데히드 제거능을 가지는 필터.
[화학식 3b]
Figure pat00057

[화학식 3c]
Figure pat00058

[화학식 3d]
Figure pat00059

(상기 식들에서, R8, R9는 각각 독립적으로 수소 또는 C1~C4의 알킬기이고, X는 산소(O), 황(S) 또는 질소(N)이다.)
The method according to claim 1,
Wherein the cyclic derivative is selected from the group consisting of compounds represented by the following formulas (3b) to (3d) or salts thereof: (1) a heavy metal and a formaldehyde-removing filter.
(3b)
Figure pat00057

[Chemical Formula 3c]
Figure pat00058

(3d)
Figure pat00059

(Wherein R 8 and R 9 are each independently hydrogen or a C 1 -C 4 alkyl group and X is oxygen (O), sulfur (S) or nitrogen (N).)
제1항에 있어서,
상기 트리엔틴 유도체는 하기 화학식 1e 내지 화학식 1h로 표시되는 화합물 또는 이들의 염 중에서 선택되는 것인, 중금속 및 포름알데히드 제거능을 가지는 필터.
[화학식 1e]
Figure pat00060

[화학식 1f]
Figure pat00061

[화학식 1g]
Figure pat00062

[화학식 1h]
Figure pat00063

The method according to claim 1,
Wherein the trientine derivative is selected from compounds represented by the following formulas (1e) to (1h) or salts thereof.
[Formula 1e]
Figure pat00060

(1f)
Figure pat00061

[Formula 1g]
Figure pat00062

[Chemical Formula 1h]
Figure pat00063

제1항에 있어서,
상기 사이클렌 유도체는 하기 화학식 2e 내지 화학식 2h로 표시되는 화합물 또는 이들의 염 중에서 선택되는 것인, 중금속 및 포름알데히드 제거능을 가지는 필터.
[화학식 2e]
Figure pat00064

[화학식 2f]
Figure pat00065

[화학식 2g]
Figure pat00066

[화학식 2h]
Figure pat00067

The method according to claim 1,
Wherein the cyclic derivative is selected from the group consisting of compounds represented by the following formulas (2e) to (2h) or salts thereof.
[Formula 2e]
Figure pat00064

(2f)
Figure pat00065

[Chemical Formula 2g]
Figure pat00066

[Chemical Formula 2h]
Figure pat00067

제1항에 있어서,
상기 사이클람 유도체는 하기 화학식 3e 내지 화학식 3h로 표시되는 화합물 또는 이들의 염 중에서 선택되는 것인, 중금속 및 포름알데히드 제거능을 가지는 필터.
[화학식 3e]
Figure pat00068

[화학식 3f]
Figure pat00069

[화학식 3g]
Figure pat00070

[화학식 3h]
Figure pat00071

The method according to claim 1,
Wherein the cyclic derivative is selected from the group consisting of compounds represented by the following formulas (3e) to (3h) or salts thereof.
[Formula 3e]
Figure pat00068

(3f)
Figure pat00069

[Formula 3g]
Figure pat00070

[Chemical Formula 3h]
Figure pat00071

제1항 내지 제8항 중 어느 한 항에 있어서,
상기 트리엔틴 또는 트리엔틴 유도체, 사이클렌 또는 사이클렌 유도체, 사이클람 또는 사이클람 유도체 성분은 필터 전체 중량에 대하여 0.001 ~ 5.0 중량%로 함유되는 것을 특징으로 하는, 중금속 및 포름알데히드 제거능을 가지는 필터.
9. The method according to any one of claims 1 to 8,
Characterized in that said trienetine or trienetine derivative, cyclane or cyclene derivative, cyclam or cyclam derivative component is contained in an amount of 0.001 to 5.0% by weight, based on the total weight of the filter, of heavy metal and formaldehyde filter.
제1항에 있어서,
상기 필터는 공기청정용 필터, 에어컨 필터로 이용되는 것인, 중금속 및 포름알데히드 제거능을 가지는 필터.
The method according to claim 1,
Wherein the filter is used as an air-cleaning filter, an air-conditioner filter, a filter having heavy metal and formaldehyde removing ability.
제1항에 있어서,
상기 필터는 담배 필터로 이용되는 것인, 중금속 및 포름알데히드 제거능을 가지는 필터.
The method according to claim 1,
Wherein the filter is used as a cigarette filter, the filter having heavy metal and formaldehyde removal ability.
제10항의 담배 필터를 포함하는 필터 담배.
A filter cigarette comprising the cigarette filter of claim 10.
제1항에 따른 필터를 포함하는 마스크.A mask comprising the filter according to claim 1.
KR1020170081030A 2017-06-27 2017-06-27 Filter material for removing heavy metals and formaldehyde KR20190001284A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020170081030A KR20190001284A (en) 2017-06-27 2017-06-27 Filter material for removing heavy metals and formaldehyde

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020170081030A KR20190001284A (en) 2017-06-27 2017-06-27 Filter material for removing heavy metals and formaldehyde

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020190109581A Division KR102077430B1 (en) 2019-09-04 2019-09-04 Filter material for removing heavy metals and formaldehyde

Publications (1)

Publication Number Publication Date
KR20190001284A true KR20190001284A (en) 2019-01-04

Family

ID=65018328

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020170081030A KR20190001284A (en) 2017-06-27 2017-06-27 Filter material for removing heavy metals and formaldehyde

Country Status (1)

Country Link
KR (1) KR20190001284A (en)

Similar Documents

Publication Publication Date Title
KR102077430B1 (en) Filter material for removing heavy metals and formaldehyde
RU2073005C1 (en) Metal chelate compound
CN102227424B (en) Modulators of cystic fibrosis transmembrane conductance regulator
TW200817343A (en) Method of enhancing mucosal hydration and mucosal clearance by treatment with sodium channel blockers and osmolytes
WO1994026275A1 (en) 2-pyridylmethylenepolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents
FI90865B (en) Process for the preparation of pharmaceutically useful isoquinoline derivatives
CN108137557A (en) Nrf2 conditioning agents
CA2054091A1 (en) Isoquinolinone derivatives
JPH062740B2 (en) Pharmaceutical composition
TW200940059A (en) Poly aromatic sodium channel blockers
EP2991981B1 (en) Diaminopyrazine compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof
AU2015276186B2 (en) 6-hydroxy-2,5,7,8-tetramethylchroman-compounds for the treatment of chronic obstructive airway diseases
EP3337483A1 (en) Novel annelated benzamides
KR20180044333A (en) Novel annealed phenoxyacetamide
EP3030555A1 (en) Novel pyrazine amide compounds
KR20190001284A (en) Filter material for removing heavy metals and formaldehyde
JP2001526913A (en) Polyphenol compounds or derivatives thereof used as free radical scavengers for tobacco filters
CN110582557B (en) Detergent composition for removing heavy metals and formaldehyde
RU2549546C2 (en) Aminoheteroaryl derivatives as hcn blocking agents
KR101851981B1 (en) Compositions for protecting skin
KR102067551B1 (en) Compounds for remediating the contaminated soil or water
CN115806570A (en) Novel peptide-like derivative, and pharmaceutical composition and application thereof
KR20190119553A (en) Compounds for remediating the contaminated soil or water
BG98439A (en) Quaternary ammonium derivatives of (-) and (+) 10-(1-azobicyclo /2.2.2/oct-3-il-methyl)-1oh-phenothiazine, pharmaceutical compositions on their basis and method for their preparation
KR102436259B1 (en) Hazardous substance adsorption member comprising biodegradable polymer to which natural product-derived composition is applied

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application
A107 Divisional application of patent